NEJM This Week – Audio Summaries
New medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.
All Episodes
NEJM This Week — December 19, 2024
Featuring articles on cancer cachexia, MDR tuberculosis, Ebola virus disease, and severe asthma; a review article on the nonsurgical management of chronic venous insufficiency; a case report of a woman with end-stage liver disease and headache; and Perspectives on providing effective medical care to autistic people, on independent physician associations, on face-to-face learning, and on those who are well known to us. Supplement to the New England Journal of Medicine, Vol. 391, No. 24.
December 18, 2024
NEJM This Week — December 12, 2024
Featuring articles on PCI before transcatheter aortic-valve implantation, treatments in patients with type 2 diabetes, in leprosy, in refractory adult ALL, and in ATTR cardiomyopathy; a review article on drug reaction with eosinophilia and systemic symptoms; a case report of a boy with recurrent fever; and Perspectives on an autopsy of a drug withdrawal, on clearing dense drug-patent thickets, on how a survey change sheds light on iatrogenic opioid use disorder and on being tethered. Supplement to the New England Journal of Medicine, Vol. 391, No. 23.
December 11, 2024
NEJM This Week — December 5, 2024
Featuring articles on treatments for atrial fibrillation and stable coronary disease, for chronic hepatitis B, and for metastatic breast cancer; the 30-year cardiovascular disease risk in healthy women; and prenatal screening and detection of maternal cancer; a review article on sepsis and septic shock; a case report of a woman with headache, fever, and respiratory failure; and Perspectives on Medicare’s bundled-payment programs, on handcuffs and unexpected deaths, on the Marburg outbreak in Rwanda, and on the care that saved one parent. Supplement to the New England Journal of Medicine, Vol. 391, No. 22.
December 4, 2024
NEJM This Week — November 28, 2024
Featuring articles on pembrolizumab perioperative therapy in breast cancer, reduced dose schedules or fractional doses of pneumococcal conjugate vaccine, and nivolumab plus ipilimumab in colorectal cancer; a review article on degenerative rotator-cuff disorders; a case report of a man with seizures and agitation; a Clinical Implications of Basic Research on boning up on boning up; and Perspectives on the Duffy null phenotype; on sickle cell trait, inequity, and the need for change, on “target trial emulation” for observational studies, and on a good day. Supplement to the New England Journal of Medicine, Vol. 391, No. 21.
November 27, 2024
NEJM This Week — November 21, 2024
Featuring articles on a nationwide couple-based genetic screening; adjunctive embolization for subdural hematoma; a late-liver-stage attenuated malaria vaccine; and climate change, floods, and human health; a review article on Candida auris infections; a case report of a girl with abdominal pain; and Perspectives on Medicare’s first round of drug-price negotiation; on invisible deaths; on minding the sentinel; and on Saint Didacus, fetal death, and dual loyalty. Supplement to the New England Journal of Medicine, Vol. 391, No. 20.
November 20, 2024
NEJM This Week — November 14, 2024
Featuring articles on perioperative durvalumab in bladder cancer, transcatheter valve repair for mitral regurgitation, chemoradiotherapy in gastric cancer, and lessons from England’s National Health Service; a review article on lung transplantation; a case report of a newborn with hypoxemia and a lung opacity; and Perspectives on our latest brief case studies on efforts toward equity and on forensic nurse examiners. Supplement to the New England Journal of Medicine, Vol. 391, No. 19.
November 13, 2024
NEJM This Week — November 7, 2024
Featuring articles on an invasive treatment strategy in older patients with myocardial infarction, a randomized trial of very early medication abortion, therapies in stage III melanoma, and on long Covid defined; a review article on uterine fibroids; a Clinical Problem-Solving on two sides to the story; and Perspectives on the U.S. Latino HIV crisis, on reframing cerebral palsy as a lifelong disability, and on an older patient and his physician finding an immediate, resonant connection in a haunting song recalled from long ago and far away. Supplement to the New England Journal of Medicine, Vol. 391, No. 18.
November 6, 2024
NEJM This Week — October 31, 2024
Featuring articles on semaglutide in persons with obesity and knee osteoarthritis, the addition of PI3K inhibition in breast cancer, treatments in older patients with myeloma, and total hip replacement for hip osteoarthritis; a review article on lead poisoning; a case report of a man with dyspnea after old myocardial infarction; and Perspectives on large language models and the medical record, on measuring AI against the health care we have, on the failing U.S. health system, and on the contemporary rise of pronatalism. Supplement to the New England Journal of Medicine, Vol. 391, No. 17.
October 30, 2024
NEJM This Week — October 24, 2024
Featuring articles on treatments in heart failure, advanced non–small-cell lung cancer, and Dupuytren’s contracture; a neurodevelopmental disorder caused by deletion in a long noncoding RNA; a review article on burnout and depression among physicians; a case report of a woman with confusion, aphasia, and a brain mass; a Medicine and Society article on how the idea of social contagion shaped trans medicine; and Perspectives on navigating clinicians’ conscience-based refusals, on opportunity costs of Medicare Advantage rebates, on celebrating public health, and on taking our own medicine. Supplement to the New England Journal of Medicine, Vol. 391, No. 16.
October 23, 2024
NEJM This Week — October 17, 2024
Featuring articles on nivolumab in advanced Hodgkin’s lymphoma, kidney transplantation from donors with HIV, a modular communicative leadless pacing–defibrillator system, stereotactic body radiotherapy in prostate cancer, and on how DNA sensing drives inflammation; a review article on cryoglobulinemia; a case report of a woman with dyspnea, dysphagia, and dysarthria; and a Special Report and Perspectives on the U.S. elections and health policy.
October 16, 2024
NEJM This Week — October 10, 2024
Featuring articles on beta-blocker use after myocardial infarction and treatments for cerebral adrenoleukodystrophy and for small-cell lung cancer; a review article on hairy-cell leukemia; a case report of a man with fever, myalgia, jaundice, and respiratory failure; and Perspectives on Mpox, on addressing health care cost growth, and on confirmatory trials of accelerated approval drugs. Supplement to the New England Journal of Medicine, Vol. 391, No. 14.
October 9, 2024
NEJM This Week — October 3, 2024
Featuring articles on lenacapavir for HIV prevention in cisgender women, tirzepatide for treatment of obstructive sleep apnea, lymphadenectomy for muscle-invasive bladder cancer, secondary T-cell lymphoma after CAR T-cell therapy, and immunity and early colorectal carcinogenesis; a review article on prolonged grief disorder; a Clinical Problem-Solving on avoiding rash decisions; and Perspectives on health care reform and the 2024 U.S. elections, on financial toxicity for patients from the use of AI, on the Supreme Court’s shadowy treatment of public health, and on caring for our communities. Supplement to the New England Journal of Medicine, Vol. 391, No. 13.
October 2, 2024
NEJM This Week — September 26, 2024
Featuring articles on systematic vs. targeted biopsy for prostate cancer screening, ziresovir in hospitalized infants with RSV, gene therapy for factor IX deficiency, and a phase 2 trial of tulisokibart for ulcerative colitis; a review article on neuroleptic malignant syndrome; a case report of a woman with kidney lesions and lytic bone disease; and Perspectives on Dobbs revisited, on the role of physicians on ethics committees after Dobbs, on accessible weight scales and exam tables, and on ensuring a safe and sufficient global blood supply. Supplement to the New England Journal of Medicine, Vol. 391, No. 12.
September 25, 2024
NEJM This Week — September 19, 2024
Featuring articles on long-term oxygen therapy in severe hypoxemia, reducing opioid overdose deaths, blocking CSF1R in chronic GVHD, and pomalidomide in hereditary hemorrhagic telangiectasia; a review article on central nervous system vasculitis; a case report of a man with confusion and kidney failure; a Medicine and Society on house staff unionization revisited; and Perspectives on ethical challenges in pragmatic and cluster RCTs, on the sense and sensibility of sensitivity analyses, and on there being no one in charge. Supplement to the New England Journal of Medicine, Vol. 391, No. 11.
September 18, 2024
NEJM This Week — September 12, 2024
Featuring articles on treatments in newly diagnosed chronic myeloid leukemia and RNA therapeutics in mixed hyperlipidemia; a review article on clinical approaches to firearm injury prevention; a case report of a woman with edema, arthritis, and proteinuria; and Perspectives on keeping SNAP in line with global evidence, on ingesting risk, on centering the peripheral brain, and on how health care burdens patients. Supplement to the New England Journal of Medicine, Vol. 391, No. 10.
September 11, 2024
NEJM This Week — September 5, 2024
Featuring articles on doxorubicin plus trabectedin in leiomyosarcoma, a monoclonal antibody for migraine prevention, adjunctive argatroban or eptifibatide for ischemic stroke, and a new orthonairovirus associated with febrile illness; a review article on pancreatic cysts; a case report of a man with pain and dyspnea; a Medicine and Society on building a community of medical learning; and Perspectives on supreme power, on shared savings for nursing homes, on moral injury and the global health workforce crisis, and on asking patients if they feel safe at home. Supplement to the New England Journal of Medicine, Vol. 391, No. 9.
September 4, 2024
NEJM This Week — August 22, 2024
Featuring articles on amino acid infusion and kidney protection, azithromycin to reduce childhood mortality in Niger, belzutifan in renal-cell carcinoma, and a transfusion strategy in traumatic brain injury; a review article on sexual dysfunction in women; a case report of a woman with aphasia, anemia, and a breast mass; and Perspectives on a series of brief cases on efforts toward equity and on controlling global antimicrobial resistance. Supplement to the New England Journal of Medicine, Vol. 391, No. 8.
August 21, 2024
NEJM This Week — August 15, 2024
Featuring articles on osimertinib in stage III EGFR-mutated lung cancer, cognitive motor dissociation in disorders of consciousness, rapid deployment of a brain–computer interface in ALS, and the longevity of a brain–computer interface for ALS; a review article on the genetics of chronic kidney disease; a case report of a boy with autism and decreased vision; and Perspectives on medical expertise, on collecting data on sexual orientation and gender identity, and on the pursuit of polka dots. Supplement to the New England Journal of Medicine, Vol. 391, No. 7.
August 14, 2024
NEJM This Week — August 8, 2024
Featuring articles on crinecerfont in pediatric and adult congenital adrenal hyperplasia, the postacute sequelae of SARS-CoV-2 infection, and nipocalimab in early-onset severe hemolytic disease of the fetus and newborn; a review article on frailty in older adults; a case report of a woman with postpartum anxiety and intrusive thoughts; and Perspectives on refusing to learn the lessons of Covid-19; on preparing for the next pandemic; on collective trauma and commemoration; and on an unknown family history. Supplement to the New England Journal of Medicine, Vol. 391, No. 6.
August 7, 2024
NEJM This Week — August 1, 2024
Featuring articles on belantamab mafodotin for multiple myeloma, autoantibodies targeting nephrin in podocytopathies, neutralizing anti–interleukin-10 autoantibodies in IBD; a review article on Parkinson’s disease; a Clinical Problem-Solving on going down the rabbit hole; a Medicine and Society article on race-based screening under the ethics microscope; and a Perspective on a legacy of cruelty to sexual and gender minority groups. Supplement to the New England Journal of Medicine, Vol. 391, No. 5.
July 31, 2024
NEJM This Week — July 25, 2024
Featuring articles on treatments for metabolic dysfunction–associated steatohepatitis, blinatumomab in adults with ALL, and sotorasib for KRAS G12C–driven vascular malformations; a review article on HIV-associated tuberculosis; a case report of a woman with rapidly progressive dementia; and Perspectives on the abandonment of people subjected to sexual and intimate partner violence, on multicancer early detection tests, and on coping in the setting of serious illness.
July 24, 2024
NEJM This Week — July 18, 2024
Featuring articles on tenecteplase for ischemic stroke within 4.5 to 24 hours after the stroke, risankizumab vs. ustekinumab for Crohn’s disease, nirmatrelvir–ritonavir as Covid-19 postexposure prophylaxis, and efanesoctocog alfa in children with hemophilia A; a review article on the management of insomnia; a case report of a woman with postpartum fever, abdominal pain, and skin ulcers; and Perspectives on the ethics of relational AI, on anticipating the next pandemic, and on a first patient. Supplement to the New England Journal of Medicine, Vol. 391, No. 3.
July 17, 2024
NEJM This Week — July 11, 2024
Featuring articles on semaglutide and chronic kidney disease in type 2 diabetes, felzartamab in kidney-transplant rejection, bulevirtide and peginterferon for chronic hepatitis D, and nirsevimab and hospitalization for RSV bronchiolitis; a review article on malnutrition in adults; a case report of an infant with vomiting and hypercalcemia; and Perspectives on Medicare Advantage and consolidation’s new frontier, on orphan drugs and priorities for the future, on funding post-authorization vaccine-safety science, and on standing on her own two feet. Supplement to the New England Journal of Medicine, Vol. 391, No. 2.
July 10, 2024
NEJM This Week — July 4, 2024
Featuring articles on stress ulcer prophylaxis during invasive mechanical ventilation, new therapies for hereditary angioedema, tissue factor–directed therapy in cervical cancer, and normalization of C1 inhibitor in a patient with hereditary angioedema; a review article on acute abdomen in the modern era; a Clinical Problem-Solving article on aggregating the loose threads; a Medicine and Society on a case for the Medical Civil Rights Act; and Perspectives on academic freedom in America; on water pollution, health, and medicine’s duty to engage; and on to forgive, divine. Supplement to the New England Journal of Medicine, Vol. 391, No. 1.
July 3, 2024
NEJM This Week — June 27, 2024
Featuring articles on treatments for eosinophilic esophagitis, reteplase versus alteplase for acute ischemic stroke, dupilumab for COPD with type 2 inflammation, and brigatinib in NF2-related schwannomatosis; a review article on amyloidosis; a case report of a man with recurrent fever and liver lesions; and Perspectives on Alzheimer’s disease, biomarkers, and mAbs; on climate litigation for protecting public health; on carbon-footprint analyses in RCTs; and on the phantom of the organ. Supplement to the New England Journal of Medicine, Vol. 390, No. 24.
June 26, 2024
NEJM This Week — June 20, 2024
Featuring articles on combination therapy for diffuse large B-cell lymphoma, autosomal dominant Alzheimer’s disease, noninvasive ventilation for preoxygenation during emergency intubation, a novel anti-CD38 antibody in immune thrombocytopenia, and a glucose-responsive insulin for type 2 diabetes; a review article on congenital and acquired Chiari syndrome; a case report of a man with arthritis and rash; and Perspectives on ethics and innovative research on brain diseases, on sustaining and scaling up street medicine, and on the maternal crossroad. Supplement to the New England Journal of Medicine, Vol. 390, No. 23.
June 19, 2024
NEJM This Week — June 13, 2024
Featuring articles on T-cell cancer after CAR T-cell therapy, the early diagnosis and treatment of COPD and asthma, and the implications of race adjustment in lung-function equations; a review article on diets; a case report of a woman with the worst headache of her life; and Perspectives on efforts toward equity and on feeling guilty. Supplement to the New England Journal of Medicine, Vol. 390, No. 22.
June 12, 2024
NEJM This Week — June 6, 2024
Featuring articles on neoadjuvant immunotherapy for dMMR colon cancer, TAVR in patients with a small aortic annulus, gene editing and retinal degeneration, and the genetic diagnosis of rare diseases; a review article on disorders of magnesium; a case report of a woman with metastatic breast cancer; and a Perspective on malicious midwives, fruitful vines, and bearded women. Supplement to the New England Journal of Medicine, Vol. 390, No. 21.
June 5, 2024
NEJM This Week — May 30, 2024
Featuring articles on aficamten for obstructive hypertrophic cardiomyopathy; early blood-pressure reduction in acute stroke; interferon-γ in autoimmune polyendocrine syndrome type 1; video laryngoscopy for intubation in neonates; hunger, thirst, and Buridan’s ass; and global health law for a safer and fairer world; a review article on medical AI and human values; a case report of a man with a pustular rash; and Perspectives on an approach toward a tobacco-free generation, on fair allocation of GLP-1 and dual GLP-1–GIP receptor agonists, on corporate medicine 2.0, and on snapshots. Supplement to the New England Journal of Medicine, Vol. 390, No. 20.
May 29, 2024
NEJM This Week — May 16, 2024
Featuring articles on andexanet and factor Xa inhibitor–associated hemorrhage, perioperative nivolumab in resectable lung cancer, olezarsen for familial chylomicronemia syndrome, and olezarsen for hypertriglyceridemia; a review article on climate change, extreme heat, and health; a case report of a woman with worsening rash; and Perspective articles on focusing on health care equity, on underestimated challenges for social care initiatives, on integrating public health and health care, and on learning to say goodbye. Supplement to the New England Journal of Medicine, Vol. 390, No. 19.
May 15, 2024
NEJM This Week — May 9, 2024
Featuring articles on gene editing in severe sickle cell disease and in transfusion-dependent β-thalassemia, thrombectomy for stroke with a large infarct, and recombinant ADAMTS13 in life-threatening immune thrombotic thrombocytopenic purpura; a review article on taste physiology; a case report of a woman with back pain, leg stiffness, and falls; and Perspective articles on the public good on the docket, on reengineering addiction, on welcoming the era of gene editing in medicine, and on all’s fair in love and work. Supplement to the New England Journal of Medicine, Vol. 390, No. 18.
May 8, 2024
NEJM This Week — May 2, 2024
Featuring articles on a monoclonal antibody to prevent malaria, apolipoprotein A1 and outcomes after myocardial infarction, transcatheter or surgical treatment of aortic-valve stenosis, and recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura; a review article on cryptococcal disease in diverse hosts; a Clinical Problem-Solving on the meat of the matter; and a Perspective on Journal voices in the civil rights era. Supplement to the New England Journal of Medicine, Vol. 390, No. 17.
May 1, 2024
NEJM This Week — April 25, 2024
Featuring articles on empagliflozin after acute myocardial infarction, CD7 CAR T cells with allogeneic stem-cell transplantation, FFR-guided complete revascularization for STEMI, and nutrition for moderate-to-late preterm infants; a review article on age-related hearing loss; a case report of a man with leg weakness; and Perspective articles on hospital consolidation and physician unionization, on the myth of the free market for pharmaceuticals, and on going beyond code status. Supplement to the New England Journal of Medicine, Vol. 390, No. 16.
April 24, 2024
NEJM This Week — April 18, 2024
Featuring articles on adjuvant pembrolizumab after surgery in renal-cell carcinoma, beta-blockers after MI with preserved ejection fraction, a microaxial flow pump for STEMI and cardiogenic shock, and semaglutide in patients with heart failure and diabetes; a review article on retinoblastoma; a case report of a woman with confusion, aphasia, and abnormal head imaging; and Perspectives on expanding applications of clinical genetic testing, on twenty-five years after Columbine, on advocating for a healthy response to climate change, and on the silver resident. Supplement to the New England Journal of Medicine, Vol. 390, No. 15.
April 17, 2024
NEJM This Week — April 11, 2024
Featuring articles on alectinib in ALK-positive lung cancer, minimally invasive removal of cerebral hematomas, and CAR T-cell–mediated responses in recurrent glioblastoma; a review article on energy and macronutrients across the life span; a case report of a woman with falls and cognitive decline; a Medicine and Society on money as medicine; and Perspectives on back to the future in Alabama, on the end of B/Yamagata influenza transmission, and on the plight of DEI leaders. Supplement to the New England Journal of Medicine, Vol. 390, No. 14.
April 10, 2024
NEJM This Week — April 4, 2024
Featuring articles on omitting axillary dissection in breast cancer with sentinel-node metastasis, a trial of lixisenatide in early Parkinson’s disease, nirmatrelvir–ritonavir in outpatients with Covid-19, and hospitalization for chronic kidney disease; a review article on the prevention of cardiovascular disease in type 1 diabetes; a case report of a woman with hyperglycemia refractory to insulin; and a Perspective article on Nazism and the Journal. Supplement to the New England Journal of Medicine, Vol. 390, No. 13.
April 3, 2024
NEJM This Week — March 21, 2024
Featuring articles on autism and prenatal exposure to antiseizure medication, ribociclib plus endocrine therapy in early breast cancer, gene therapy for giant axonal neuropathy, and anti–interleukin-23 in immunodeficiency; a review article on wearable digital health technologies in clinical care; a case report of a man with a fall; and Perspective articles on physicians, spirituality, and compassionate care; on the risks posed by immediate release of test results to patients; and on what one author did not tell the medical student. Supplement to the New England Journal of Medicine, Vol. 390, No. 12.
March 20, 2024
NEJM This Week — March 14, 2024
Featuring articles on a blood-based test for colorectal cancer screening, a multitarget stool DNA test for colorectal cancer, iptacopan for paroxysmal nocturnal hemoglobinuria, and preterm birth and other outcomes of maternal RSV vaccination; a review article on cerebral cavernous malformations; a case report of a man with cardiac arrest, cardiogenic shock, and hypoxemia; and Perspective articles on vertical integration and American medicine; on aspirin, preeclampsia, and racism; and on a shift in the night. Supplement to the New England Journal of Medicine, Vol. 390, No. 11.
March 13, 2024
NEJM This Week — March 7, 2024
Featuring articles on an antibody–drug conjugate in untreated urothelial cancer, omalizumab for multiple food allergies, microplastics and nanoplastics in carotid plaque, and benralizumab or mepolizumab for eosinophilic granulomatosis with polyangiitis; a review article on the health effects of endocrine-disrupting chemicals; a Clinical Problem-Solving on peeling and plummeting; a Medicine and Society on beyond moral injury; and a Perspective article on eugenics in the Journal. Supplement to the New England Journal of Medicine, Vol. 390, No. 10.
March 6, 2024
NEJM This Week — February 29, 2024
Featuring articles on a trial of seladelpar in primary biliary cholangitis, a trial of elafibranor in primary biliary cholangitis, cognition and memory after Covid-19, and simple versus radical hysterectomy in women with low-risk cervical cancer; a review article on cardiac rehabilitation; a case report of a woman with alternating sixth cranial nerve palsy; and a Perspective article on practicing medicine in the culture wars. We also describe a new cases series on efforts toward equity in health care.Supplement to the New England Journal of Medicine, Vol. 390, No. 9.
February 28, 2024
NEJM This Week — February 22, 2024
Featuring articles on CD19 CAR T-cell therapy in autoimmune disease, tenecteplase for stroke at 4.5 to 24 hours, biomarker changes in years before Alzheimer’s disease, and a hepcidin mimetic in polycythemia vera; a review article on wearable digital health technologies for epilepsy; a case report of a man with fatigue and night sweats; and Perspective articles on direct-to-consumer platforms for antiobesity medications, on childhood obesity prevention, and on what is a mentor. Supplement to the New England Journal of Medicine, Vol. 390, No. 8.
February 21, 2024
NEJM This Week — February 15, 2024
Featuring articles on frexalimab in multiple sclerosis, e-cigarettes for smoking cessation, cefepime–taniborbactam for complicated UTI, and the treatment of Wolman’s disease in an infant; review articles on treatment-resistant depression in older adults and on Behçet’s syndrome; a case report of a man with fevers; and Perspective articles on ethical issues in safety-net health systems, on secondary cancers after CAR T-cell therapy, and on being worried about white-cell counts. Supplement to the New England Journal of Medicine, Vol. 390, No. 7.
February 14, 2024
NEJM This Week — February 8, 2024
Featuring articles on a phase 3 trial of resmetirom in NASH with liver fibrosis, an interleukin-23–receptor antagonist for plaque psoriasis, the neurovascular complications of F. solani meningitis, and on ocular gene therapy; a review article on coccidioidomycosis and histoplasmosis; a case report of a man with fever and headache after international travel; Medicine and Society articles on a physician attack on the FDA and on being well while doing well; and Perspective articles on the risks of normalizing parental vaccine hesitancy, on advanced HIV as a neglected disease, on the challenge of common chronic diseases, and on “the saddest waste”. Supplement to the New England Journal of Medicine, Vol. 390, No. 6.
February 7, 2024
NEJM This Week — February 1, 2024
Featuring articles on an attenuated tetravalent dengue vaccine, skin antisepsis before fracture surgery, N-acetyl-L-leucine in Niemann–Pick Disease type C, in vivo CRISPR-Cas9 treatment for hereditary angioedema, and on seeing medicine more as a job than a calling; a review article on cardiac implantable electronic devices; a Clinical Problem-Solving on flipping the switch; and a Perspective article on explaining health inequities. Supplement to the New England Journal of Medicine, Vol. 390, No. 5.
January 31, 2024
NEJM This Week — January 25, 2024
Featuring articles on daratumumab in myeloma therapy, the early treatment of patent ductus arteriosus with ibuprofen, measurable residual disease in chronic lymphocytic leukemia, hospital prices for physician-administered drugs, and on Asian Americans and racial justice in medicine; a review article on wearable technologies in cardiovascular medicine; a case report of an infant with inconsolable crying and weakness; and Perspective articles on minding the gap, on transforming population health, and on the heartbeat. Supplement to the New England Journal of Medicine, Vol. 390, No. 4.
January 24, 2024
NEJM This Week — January 18, 2024
Featuring articles on testosterone treatment and fractures in men, long-term resynchronization–defibrillation therapy for heart failure, azithromycin to prevent infant mortality in Burkina Faso, oral simnotrelvir for adult patients with Covid-19, understanding liability risk from health care AI tools, and the rise of house staff unions; a review article on syphilis during pregnancy and congenital syphilis; a case report of a woman with melanoma and fever; and Perspective articles on responding to medical errors, on looking AHEAD to state global budgets for health care, and on broken both ways. Supplement to the New England Journal of Medicine, Vol. 390, No. 3.
January 17, 2024
NEJM This Week — January 11, 2024
Featuring articles on apixaban for stroke prevention in subclinical atrial fibrillation, repotrectinib for ROS1 fusion–positive lung cancer, acoramidis in transthyretin amyloid cardiomyopathy, low-dose calcium supplementation in pregnancy, and the financialization of health in the United States; a review article on peripartum cardiomyopathy; a case report of a woman with bleeding after a snakebite; and Perspective articles on the overdose crisis among U.S. adolescents, on accuracy and equity in clinical risk prediction, on centering women of color in academic medicine, and on the buddy system. Supplement to the New England Journal of Medicine, Vol. 390, No. 2.
January 10, 2024
NEJM This Week — January 4, 2024
Featuring articles on a drug-eluting scaffold for infrapopliteal disease, a phase 2 trial of sibeprenlimab in IgA nephropathy, liquefied petroleum gas cooking and the effects on severe infant pneumonia and on stunting in infants; a review article on communicating about serious illness and end of life; a Clinical Problem-Solving describing a swell diagnosis; and Perspective articles on the Journal’s historical “Indian Problem”. Supplement to the New England Journal of Medicine, Vol. 390, No. 1.
January 3, 2024
NEJM This Week — December 28, 2023
Featuring articles on dual or single antiplatelet treatment up to 72 hours after stroke, nirsevimab for prevention of RSV hospitalization in infants, sparsentan in focal segmental glomerulosclerosis, transfusion strategy in patients with myocardial infarction and anemia, and the effect of alcohol reduction on cancer incidence; a review article on wearable technology in clinical practice for depressive disorder; a case report of a woman with cough and shortness of breath; and Perspective articles on community-based doulas, on a new era for research funded by the U.S. government, and on the poet as patient. Supplement to the New England Journal of Medicine, Vol. 389, No. 27.
December 27, 2023
NEJM This Week — December 21, 2023
Featuring articles on percutaneous coronary intervention for stable angina, doxycycline prophylaxis to prevent STIs in women, simvastatin for critically ill patients with Covid-19, and melioidosis in Mississippi; a review article on eye infections; a case report of a woman with chronic diarrhea and skin changes; and Perspective articles on when patients lose decision-making capacity, on silencing the FDA’s voice, and on being hidden behind bars. Supplement to the New England Journal of Medicine, Vol. 389, No. 26.
December 20, 2023
NEJM This Week — December 14, 2023
Featuring articles on semaglutide for prevention of cardiovascular events, an mRNA-based RSV PreF vaccine in older adults, recombinant or standard-dose influenza vaccine, tebentafusp in metastatic uveal melanoma, and on the predominance of Medicare Advantage; a review article on cannabis-related disorders and toxic effects; a case report of a woman with abnormal movements and confusion; and Perspective articles on medicine’s lessons for AI regulation, on “unwinding” continuous Medicaid coverage, and on something for sleep. Supplement to the New England Journal of Medicine, Vol. 389, No. 25.
December 13, 2023
NEJM This Week — December 7, 2023
Featuring articles on sotorasib plus panitumumab in KRAS-mutated colorectal cancer, baricitinib and β-cells in new-onset type 1 diabetes, teplizumab in youth with new-onset type 1 diabetes, and mirvetuximab soravtansine in FRα-positive, platinum- resistant ovarian cancer; a review article on waterborne disease sensitivity to climate change; a Clinical Problem-Solving on collecting puzzle pieces; and we introduce a new series on Historical Injustices in Medicine and the Journal with our first Perspective article on Slavery and the Journal. Supplement to the New England Journal of Medicine, Vol. 389, No. 23.
December 6, 2023
NEJM This Week — November 30, 2023
Featuring articles on levothyroxine for unstable brain-dead heart donors, amivantamab in lung cancer with EGFR exon 20 insertions, amikacin to prevent ventilator-associated pneumonia, and tarlatamab in small-cell lung cancer, a new series on wearable digital health technology with a review article on digital technology for diabetes; a case report of a man with sickle cell disease and right hip pain; and Perspectives on coverage for emerging technologies, on methadone clinic engagement and cancer care, and on learning from the bomb. Supplement to the New England Journal of Medicine, Vol. 389, No. 22.
November 29, 2023
NEJM This Week — November 23, 2023
Featuring articles on osimertinib and chemotherapy in EGFR-mutated non–small-cell lung cancer, transcatheter aortic-valve replacement in low-risk patients at five years, erdafitinib or chemotherapy in urothelial carcinoma, and liver transplantation for Mahvash disease; a review article on postmenopausal osteoporosis; a case report of a man with diabetes and kidney cysts; and Perspectives on opening the door to international medical graduates, on community-engaged research, and on woman, life, freedom. Supplement to the New England Journal of Medicine, Vol. 389, No. 21.
November 22, 2023
NEJM This Week — November 16, 2023
Featuring articles on selpercatinib in RET fusion–positive NSCLC, selpercatinib in RET-mutant medullary thyroid cancer, gantenerumab in early Alzheimer’s disease, and stimulated copeptin to diagnose AVP deficiency; a review article on liver transplantation; a case report of a woman with waxing and waning pulmonary nodules; and Perspective articles on Rift Valley fever, on implanting a recalled device, and on biopsies from healthy volunteers in precision medicine. Supplement to the New England Journal of Medicine, Vol. 389, No. 20.
November 15, 2023
NEJM This Week — November 9, 2023
Featuring articles on genetic variation and life span in Iceland, botulinum toxin for head tremor, decolonization in nursing homes to prevent infection, nivolumab plus chemotherapy in urothelial carcinoma, pembrolizumab in pregnancy, and on after affirmative action; a review article on catatonia; a case report of a woman with loss of consciousness and thrombocytopenia; and Perspective articles on how the FDA should evaluate psychedelic medicine, on federal oversight of laboratory-developed tests, and on the corporate divorce between two major Boston medical institutions. Supplement to the New England Journal of Medicine, Vol. 389, No. 19.
November 8, 2023
NEJM This Week — November 2, 2023
Featuring articles on thalidomide for recurrent bleeding due to small-intestinal angiodysplasia, pulsed field ablation for paroxysmal atrial fibrillation, perioperative chemoimmunotherapy in lung cancer, and corin and cardiac phenotypes; a review article on cystic fibrosis; a Clinical Problem-Solving on being encased in peril; and Perspective articles on minimum-staffing rules for U.S. nursing homes, on reforming pharmacy benefit managers, on scaling up point-of-care fentanyl testing, and on familiar shadows. Supplement to the New England Journal of Medicine, Vol. 389, No. 18.
November 1, 2023
NEJM This Week — October 26, 2023
Featuring articles on patisiran for transthyretin cardiac amyloidosis, automated insulin delivery in pregnancy complicated by diabetes, nemolizumab for prurigo nodularis, convalescent plasma for Covid-19–induced ARDS, and debt collection in American medicine; a case report of a man with shortness of breath; and Perspective articles on climate, health, and equity under the Farm Bill; on indigenous health perspectives on the Lāhainā fires, on whether price negotiations delay cancer-drug launches, and on the standard of care. Supplement to the New England Journal of Medicine, Vol. 389, No. 17.
October 25, 2023
NEJM This Week — October 19, 2023
Featuring articles on on enzalutamide and leuprolide in prostate cancer, optical coherence tomography (OCT)–guided versus angiography-guided PCI, vancomycin and cefazolin prophylaxis in arthroplasty, and on OCT and eye care; a review article on the syndrome of inappropriate antidiuresis; a case report of a woman with recurrent hemorrhagic pericardial effusion; and Perspective articles on Yellow Jack’s potential return to the American South; on wedding websites, free speech, and adverse drug effects; and on a chance to modernize health care behind bars. Supplement to the New England Journal of Medicine, Vol. 389, No. 16.
October 18, 2023
NEJM This Week — October 12, 2023
Featuring articles on dexamethasone for TB meningitis in HIV-positive adults, the timing of complete revascularization after myocardial infarction, catheter ablation for advanced heart failure and AFib, ceftobiprole for Staph. aureus bacteremia, and on AlphaFold being recognized through a Lasker Award; a review article on Shiga toxin–producing E. coli and the hemolytic–uremic syndrome; a case report of a man with involuntary movements and unresponsiveness; and Perspective articles on whether pandemics ever end, on the new over-the-counter oral contraceptive pill, and on a reason to retire. Supplement to the New England Journal of Medicine, Vol. 389, No. 15.
October 11, 2023
NEJM This Week — October 5, 2023
Featuring articles on sarilumab for relapsing polymyalgia rheumatica; modifiable risk factors, cardiovascular disease, and mortality; extracorporeal life support in cardiogenic shock; and esketamine vs. quetiapine for treatment-resistant depression; a review article on stem-cell aging and precancer evolution; a Clinical Problem-Solving on digging into the histology; and Perspective articles on preventing heat-related illness among outdoor workers, on countering the health disinformation machine, and on dismantling the overpolicing of Black medical trainees. Supplement to the New England Journal of Medicine, Vol. 389, No. 14.
October 4, 2023
NEJM This Week — September 28, 2023
Featuring articles on anticoagulation and atrial high-rate episodes, tight blood-glucose control in patients in the ICU, increasing artemisinin-resistant malaria in Eritrea, the death of a patient after high-dose gene therapy, and on antiracist documentation practices; a review article on where medical statistics meets AI; a case report of a woman with confusion; and Perspective articles on affirmative action, population health, and hope; on threatening the global AIDS response; and on swimming. Supplement to the New England Journal of Medicine, Vol. 389, No. 13.
September 27, 2023
NEJM This Week — September 21, 2023
Featuring articles on semaglutide for heart failure in patients with obesity, inhaled fluticasone furoate for treatment of Covid-19, a trial of solanezumab in preclinical Alzheimer’s disease, and targeting the BRAF pathway in pediatric glioma; a review article on the prevention of central line–associated bloodstream infections; a case report of a woman with abdominal distention and acute kidney injury; and Perspective articles on the new USPSTF mammography recommendations, on the ethics of abortion care advocacy, and on reducing the risks of nuclear war. Supplement to the New England Journal of Medicine, Vol. 389, No. 12.
September 20, 2023
NEJM This Week — September 14, 2023
Featuring articles on ferric carboxymaltose for heart failure with iron deficiency, antibiotic prophylaxis in infants with vesicoureteral reflux, the FGF21 analogue pegozafermin in NASH, and mezigdomide in relapsed and refractory multiple myeloma; a review article on asthma in adults; a case report of a man with a rash; and Perspective articles on a doctrine in name only, on the accelerated approval program for cancer drugs, and on a shared mission. Supplement to the New England Journal of Medicine, Vol. 389, No. 11.
September 13, 2023
NEJM This Week — September 7, 2023
Featuring articles on the GLP-1 receptor agonist orforglipron for obesity, PCI in older patients with myocardial infarction, DNA editing in T-cell acute lymphoblastic leukemia, and atezolizumab in alveolar soft part sarcoma; a review article on Wilson’s disease; a Clinical Problem-Solving on how it’s all in the timing; and Perspective articles on NIH policy changes regarding international research collaborations, on alleviating medical debt in the United States, and on mass masking without mandates. Supplement to the New England Journal of Medicine, Vol. 389, No. 10.
September 6, 2023
NEJM This Week — August 31, 2023
Featuring articles on concizumab in hemophilia A or B with inhibitors, the timing of primary surgery for cleft palate, improved mass screening for nasopharyngeal carcinoma, gene editing for sickle cell disease, and on artificial sweeteners; a review article on informative artifacts in AI-assisted health care; a case report of a woman with celiac disease and upper gastrointestinal bleeding; and Perspective articles on Project NextGen, on gerineuropalliative care for patients with dementia, and on sexual and gender minority refugees. Supplement to the New England Journal of Medicine, Vol. 389, No. 9.
August 30, 2023
NEJM This Week — August 24, 2023
Featuring articles on preventing cardiovascular disease in HIV infection, the effect of hemodiafiltration or hemodialysis on mortality in kidney failure, a new KRAS G12C inhibitor in solid tumors, and on partial artemisinin resistance in malaria parasites; a review article on protein-losing enteropathy; a case report of a girl with abdominal pain and an ovarian mass; and Perspective articles on the Supreme Court and diversity in medicine, on outbreaks in U.S. migrant detention centers, on turning CMS into a health technology assessment organization, and on the clinic that cried safe. Supplement to the New England Journal of Medicine, Vol. 389, No. 8.
August 23, 2023
NEJM This Week — August 17, 2023
Featuring articles on vorasidenib for IDH-mutant low-grade glioma; a trial of dietary intervention for cognitive decline; omitting radiotherapy after breast-conserving surgery in luminal A breast cancer; gene therapy for the Crigler–Najjar syndrome; and on abortion counseling, liability, and the First Amendment; a review article on community-acquired pneumonia; a case report of a man with fever and foot pain; and Perspective articles on prioritizing mental health in the HIV/ AIDS response in Africa, on reducing health care’s climate impact, and on free and charitable clinics. Supplement to the New England Journal of Medicine, Vol. 389, No. 7.
August 16, 2023
NEJM This Week — August 10, 2023
Featuring articles on neoadjuvant therapy for lung cancer, a phase 2 trial of retatrutide for obesity, systemic inflammation and normocytic anemia in DOCK11 deficiency, and on the social determinants of health; a review article on thrombocytopenia in pregnant women; a case report of a man with a pulmonary nodule; and Perspective articles on over-the-counter access to HIV preexposure prophylaxis, on preparing physicians for the clinical algorithm era, and on reading Kafka in the hospital cafeteria. Supplement to the New England Journal of Medicine, Vol. 389, No. 6.
August 9, 2023
NEJM This Week — August 3, 2023
Featuring articles on a novel sodium channel blocker to treat acute pain, the effects of adult thymectomy, video vs. direct laryngoscopy for tracheal intubation, and on antidepressant maintenance in bipolar I depression; a review article on the neurologic consequences of preterm birth; a Clinical Problem-Solving on a race to the finish; and Perspective articles on AI and medical education, on expanding access to health care for DACA recipients, and on the freedom cure. Supplement to the New England Journal of Medicine, Vol. 389, No. 5.
August 2, 2023
NEJM This Week — July 27, 2023
Featuring articles on weekly insulin icodec or daily glargine in type 2 diabetes, an orexin receptor 2 agonist in narcolepsy, neoadjuvant therapy for rectal cancer, and cilta-cel in lenalidomide-refractory multiple myeloma; a review article on artificial intelligence in U.S. health care delivery; a case report of a young man with progressive dyspnea; and Perspective articles on a critical opportunity to improve public health data, on the future of prior-authorization reform, and on curiosity in clinical care. Supplement to the New England Journal of Medicine, Vol. 389, No. 4.
July 26, 2023
NEJM This Week — July 20, 2023
Featuring articles on dupilumab for COPD with type 2 inflammation, a maternal group B streptococcus vaccine, an RNA interference therapeutic agent for hypertension, and the antibody NI006 for depletion of cardiac amyloid; a review article on obesity in adolescents; a case report of a woman with hypotension and electrocardiographic changes; and Perspective articles on closing the vaccine-coverage gap for adults, on whether nonprofit hospitals deserve their tax exemption, on pursuing gender equity in primary care, and on the path toward a stronger post-pandemic nursing workforce. Supplement to the New England Journal of Medicine, Vol. 389, No. 3.
July 19, 2023
NEJM This Week — July 13, 2023
Featuring articles on the cardiovascular safety of testosterone therapy, targeting BRAF in papillary craniopharyngioma, prehospital tranexamic acid for severe trauma, survival with CAR T cells in relapsed lymphoma, and osimertinib in EGFR-mutated non–small-cell lung cancer; a review article on cutaneous electroanalgesia for pain relief; a case report of a man with eyelid swelling; and Perspective articles on Medicare’s plan for drug-price negotiation, on the National Health Service in the United Kingdom, and on hospital problems. Supplement to the New England Journal of Medicine, Vol. 389, No. 2.
July 12, 2023
NEJM This Week — July 6, 2023
Featuring articles on the early detection and treatment of postpartum hemorrhage, a randomized trial of bulevirtide in chronic hepatitis D, pirtobrutinib in chronic lymphocytic leukemia, and mild hypercapnia after out-of-hospital cardiac arrest; a review article on hepatitis D virus infection; a Clinical Problem-Solving describing a bumpy road to diagnosis; and Perspective articles on PEPFAR at 20, on strategic masking, and on armed-assailant preparedness drills in schools. Supplement to the New England Journal of Medicine, Vol. 389, No. 1.
July 5, 2023
NEJM This Week — June 29, 2023
Featuring articles on anticoagulation for stroke and atrial fibrillation, familial clonal hematopoiesis and long telomeres, JYNNEOS vaccine effectiveness against mpox, and mirikizumab for ulcerative colitis; a review article on artificial intelligence in molecular medicine; a case report of a man with a solitary fibrous tumor and hypoglycemia; and Perspective articles on sharing pathogen genomic sequence data; on hydrofluorocarbons, climate, and health; and on patient-assistance programs, kickbacks, and the courts. Supplement to the New England Journal of Medicine, Vol. 388, No. 26.
June 28, 2023
NEJM This Week — June 22, 2023
Featuring articles on ketamine versus ECT in treatment-resistant depression; the Eat, Sleep, Console method for neonatal opioid withdrawal; prophylaxis against graft-versus-host disease; dolutegravir as second-line HIV infection treatment; and a dual-chamber leadless pacemaker; a review article on lateral epicondylitis; a case report of a man with left foot drop; and Perspective articles on the origins of Covid-19, on equity and obesity treatment, and on the ellipsis. Supplement to the New England Journal of Medicine, Vol. 388, No. 25.
June 21, 2023
NEJM This Week — June 15, 2023
Featuring articles on craniectomy vs. craniotomy for acute subdural hematoma, glucocorticoids for chronic subdural hematoma, a cause of disabling pansclerotic morphea, and antagonistic leptin variants and the treatment of obesity; a review article on squamous-cell carcinoma; a case report of a woman with dyspnea and tachypnea; and Perspective articles on xylazine, on the Jackson water crisis, and on testing for fentanyl. Supplement to the New England Journal of Medicine, Vol. 388, No. 24.
June 14, 2023
NEJM This Week — June 8, 2023
Featuring articles on outcomes with donor hearts after circulatory death, treatment of gestational diabetes in early pregnancy, and anti-PD1 therapy plus chemotherapy in endometrial cancer; a review article on posterior reversible encephalopathy syndrome; a case report of a woman with fatigue and eosinophilia; and Perspective articles on moving toward comprehensive care for long Covid, on workplace accommodations for long Covid, and on over-the-counter hearing aids. Supplement to the New England Journal of Medicine, Vol. 388, No. 23.
June 7, 2023
NEJM This Week — June 1, 2023
Featuring articles on tirofiban for stroke, a five-year follow-up after transcatheter repair of secondary mitral regurgitation, diagnostic imaging for pediatric forearm fractures, and AKT pathway inhibition in HR-positive breast cancer; a review article on adipose tissue and insulin sensitivity; a Clinical Problem-Solving describing a wrong turn; and Perspective articles on ensuring a reliable platelet supply, on supporting robust teamwork, and on an invitation to lunch. Supplement to the New England Journal of Medicine, Vol. 388, No. 22.
May 31, 2023
NEJM This Week — May 25, 2023
Featuring articles on hydrocortisone in severe community-acquired pneumonia, a meningococcal vaccine in Mali and Gambia, platelet transfusion before CVC placement in patients with thrombocytopenia, and upadacitinib therapy for Crohn’s disease; a review article on using AI to interpret medical images; a case report of a boy with depression and hypotension; and Perspective articles on U.S. law and discrimination in health care, on enhancing regulations to reduce exposure to PFAS, and on public health’s role in a post-Dobbs world. Supplement to the New England Journal of Medicine, Vol. 388, No. 21.
May 24, 2023
NEJM This Week — May 18, 2023
Featuring articles on transcatheter repair for tricuspid regurgitation, rifapentine in household contacts of persons with leprosy, peresolimab for rheumatoid arthritis, and emodepside for T. trichiura and hookworm infections; a review article on tricuspid regurgitation; a case report of a man with paresthesia of the arms and legs; and Perspective articles on advancing community living for people with disabilities, on essential steps for abolishing disability injustice, and on the thin pane. Supplement to the New England Journal of Medicine, Vol. 388, No. 20.
May 17, 2023
NEJM This Week — May 11, 2023
Featuring articles on anti-CD20 antibodies and venetoclax in chronic lymphocytic leukemia, epicutaneous immunotherapy in toddlers with peanut allergy, cabozantinib in advanced renal-cell carcinoma, and racial inequality in the receipt of medications for opioid use disorder; a review article on HPV vaccination; a case report of a man with redness of the right eye; and Perspective articles on addressing serious illness care in Medicare Advantage, on corporate citizenship and institutional responses post-Dobbs, and on ethical conflicts for clinicians under Tennessee abortion law. Supplement to the New England Journal of Medicine, Vol. 388, No. 19.
May 10, 2023
NEJM This Week — May 4, 2023
Featuring articles on interrupting therapy to attempt pregnancy after breast cancer, trifluridine–tipiracil and bevacizumab in colorectal cancer, imaging- or angiography-guided PCI for complex lesions, and idiopathic CD4 lymphocytopenia; a review article on neonatal seizures; a Clinical Problem-Solving describing a diagnostic sequence; and Perspective articles on combating West Nile virus disease, on falling insulin prices, on next steps in policy reforms to address the overdose crisis, and on the breast biopsy and the Buddhist half-smile. Supplement to the New England Journal of Medicine, Vol. 388, No. 18.
May 3, 2023
NEJM This Week — April 27, 2023
Featuring articles on a 15-year follow-up of prostate cancer therapies, on deciphering developmental disorders, blinatumomab in infant acute lymphoblastic leukemia, and a BCG vaccination against Covid-19; a review article on advances in AI for infectious-disease surveillance; a case report of a woman with abdominal pain and jerking movements; and Perspective articles on access to biomedical innovation, on helping people stop smoking, and on racial affinity group caucusing in medical education. Supplement to the New England Journal of Medicine, Vol. 388, No. 17.
April 26, 2023
NEJM This Week — April 20, 2023
Featuring articles on an RSV vaccine in pregnancy, an RSV vaccine in older adults, sotatercept for pulmonary arterial hypertension, the burden of typhoid and paratyphoid fever in India, cerebral oximetry in extremely preterm infants, and on immune checkpoint inhibitors; a case report of a woman with muscle weakness and myalgia; and Perspective articles on wastewater surveillance for infectious disease, on exacerbating health inequity, and on the breast or bottle. Supplement to the New England Journal of Medicine, Vol. 388, No. 16.
April 19, 2023
NEJM This Week — April 13, 2023
Featuring articles on bempedoic acid in statin-intolerant patients, tranexamic acid to prevent hemorrhage after cesarean delivery, an oral melanocortin receptor agonist in porphyria, the influence of blood-donor sex on recipient mortality, and on air pollution, mortality, race, and social class; a review article on screening for prostate cancer; a case report of a man with mantle-cell lymphoma and hypoxemia; and Perspective articles on the Courts’ disregard for women’s health and safety, on care integration for dually eligible beneficiaries, and on treating chronic pain in sickle cell disease. Supplement to the New England Journal of Medicine, Vol. 388, No. 15.
April 12, 2023
NEJM This Week — April 6, 2023
Featuring articles on thrombectomy for large ischemic strokes, CAR T cells for relapsed or refractory neuroblastoma, postexposure doxycycline to prevent bacterial STIs, and the genetic risk of low-grade glioma; a review article on primary Budd–Chiari syndrome; a Clinical Problem-Solving on an alternate explanation; and Perspective articles on ensuring public trust in an empowered FDA, on why diverse clinical trial participation matters, and on a quixotic quest for independence. Supplement to the New England Journal of Medicine, Vol. 388, No. 14.
April 5, 2023
NEJM This Week — March 30, 2023
Featuring articles on azithromycin to prevent sepsis or death during birth, transcatheter arterialization for limb ischemia, gene–environment interactions and the risk of gastric cancer, vedolizumab for the treatment of chronic pouchitis, a general AI chatbot for medicine, and on dark-alley ethics; a review article on artificial intelligence and machine learning in clinical medicine, 2023; a case report of a man with convulsions; and Perspective articles on the end of a declared public health emergency, on medication-associated diethylene glycol mass poisoning, and on digital minimalism. Supplement to the New England Journal of Medicine, Vol. 388, No. 13.
March 29, 2023
NEJM This Week — March 23, 2023
Featuring articles on augmenting or switching antidepressants in older adults, lebrikizumab for moderate-to-severe atopic dermatitis, the acute health effects of coffee consumption, Covid-19 staff testing and outcomes in nursing homes, and an mRNA influenza vaccine; a review article on right ventricular failure; a case report of a man with shortness of breath and proteinuria; and Perspective articles on the trials and triumphs of health care antitrust law, on unwinding continuous Medicaid enrollment, and on delirium. Supplement to the New England Journal of Medicine, Vol. 388, No. 12.
March 22, 2023
NEJM This Week — March 16, 2023
Featuring articles on inaxaplin in persons with two APOL1 variants, expectant management or early ibuprofen for patent ductus arteriosus, closed-loop control in children with diabetes, BCMA-specific CAR T cells in refractory myeloma; a review article on translation defects in neurodegenerative diseases; a case report of a woman with refractory hemolytic anemia; and Perspective articles on Medicare Part D coverage of antiobesity medications, on the erosion of judicial deference to the FDA, and on pregnancy and residency. Supplement to the New England Journal of Medicine, Vol. 388, No. 11.
March 15, 2023
NEJM This Week — March 9, 2023
Featuring articles on a shorter course for tuberculosis treatment, device-based fever prevention after cardiac arrest, an inhibitor of γ-secretase in desmoid tumors, and the climate gap and the color line; a review article on outcomes after critical illness; a case report of a man with Covid-19, respiratory failure, and rashes; and Perspective articles on diversifying the physician workforce, on electronic prior authorization for prescription drugs, and on when cancer cured pain. Supplement to the New England Journal of Medicine, Vol. 388, No. 10.
March 8, 2023
NEJM This Week — March 2, 2023
Featuring articles on hydrochlorothiazide and the prevention of kidney stones, the treatment of severe scrub typhus, nicotinamide for skin-cancer chemoprevention, neoadjuvant pembrolizumab in advanced melanoma, cancer screening after paid-sick-leave mandates, and health care in U.S. correctional facilities; a Clinical Problem-Solving describing a rocky resurgence; and Perspective articles on investing in national HIV PrEP preparedness, on health care equity for undocumented immigrants, on the injury equity framework, and on aligning quality measures across CMS. Supplement to the New England Journal of Medicine, Vol. 388, No. 9.
March 1, 2023
Not Otherwise Specified
In “Not Otherwise Specified,” Dr. Lisa Rosenbaum, cardiologist and national correspondent for the New England Journal of Medicine, defies our sound-bite culture to go deep with some of medicine’s most innovative thinkers. Her guests’ stories and ideas about health care’s toughest challenges and greatest promise may change the way you think about medicine, health, and society.
February 22, 2023
NEJM This Week — February 23, 2023
Featuring articles on focused ultrasound ablation for Parkinson’s disease, gene therapy for hemophilia A at 2 years, gene therapy for hemophilia B, and a PARP inhibitor in prostate cancer with DNA-repair defects; a review article on acute kidney injury in patients with cirrhosis; a case report of a man with recurrent strokes; and Perspective articles on fraud, abuse, and financial conflicts of interest; on protecting the legitimacy of medical expertise; and on the princess and the he. Supplement to the New England Journal of Medicine, Vol. 388, No. 8.
February 22, 2023
NEJM This Week — February 16, 2023
Featuring articles on the omission of radiation in localized breast cancer, two trials of respiratory syncytial virus vaccines in older adults, a Covid-19 vaccine in young children, and uncoupling metastasis from tumorigenesis; a review article on transient global amnesia; a case report of a man with interstitial lung disease, fever, and myalgias; and Perspective articles on choosing the right path toward polio eradication, on the journey to RSV vaccines, and on looking after our own. Supplement to the New England Journal of Medicine, Vol. 388, No. 7.
February 15, 2023
NEJM This Week — February 9, 2023
Featuring articles on sublobar resection in small lung cancers, fluid management for sepsis-induced hypotension, difelikefalin for notalgia paresthetica, pegylated interferon lambda for Covid-19, and public health policy to end mass incarceration; a review article on rheumatoid arthritis; a case report of a man with abnormal results on testing of liver function; and Perspective articles on bivalent Covid-19 vaccines, on preventing market entry of generics and biosimilars, and on when clinicians should say the word “hospice”. Supplement to the New England Journal of Medicine, Vol. 388, No. 6.
February 8, 2023
NEJM This Week — February 2, 2023
Featuring articles on baxdrostat for treatment-resistant hypertension, VV116 versus nirmatrelvir for Covid-19, hypothermia or machine perfusion in kidney donors, effectiveness of the 4CMenB vaccine in children, implications of the 2022 election for health policy, and animal models and psychedelic research; a review article on innate immunity; a Clinical Problem-Solving on a breathtaking discovery; and Perspective articles on facing the new Covid-19 reality and on equity in global health research. Supplement to the New England Journal of Medicine, Vol. 388, No. 5.
February 1, 2023
NEJM This Week — January 26, 2023
Featuring articles on extracorporeal CPR for cardiac arrest, efanesoctocog alfa in severe hemophilia A, zanubrutinib in chronic lymphocytic leukemia, and on using rescaled cystatin C to estimate GFR; a review article on antiretroviral therapy and adverse pregnancy outcomes; a case report of a girl with abdominal pain and bloody diarrhea; and Perspective articles on regulating reproductive medicine without Roe, on sources of innovation in gene therapies, and on the promise. Supplement to the New England Journal of Medicine, Vol. 388, No. 4.
January 25, 2023
NEJM This Week — January 19, 2023
Featuring articles on aspirin or heparin thromboprophylaxis after a fracture, omicron neutralization with a bivalent vaccine boost, futibatinib for intrahepatic cholangiocarcinoma, and psychosocial functioning in transgender youth; a review article on periprosthetic joint infection; a case report of a man with dizziness and altered mental status; and Perspective articles on social isolation and loneliness as medical issues, on Medicare overpayment for outpatient medication, on being better off at home, and on hope after firearm trauma. Supplement to the New England Journal of Medicine, Vol. 388, No. 3.
January 18, 2023
Intention to Treat
“Intention to Treat,” hosted by health care journalist Rachel Gotbaum, draws on the world-class expertise of the New England Journal of Medicine to present breaking news and incisive analysis of critical and timely issues in medicine and health care. Through interviews with NEJM editors, specialized experts, physicians, and affected patients, each episode explores a story-behind-the-story, giving listeners needed context and a deeper understanding of complex research, cutting-edge medical interventions, and urgent health policy debates that affect patients and the clinicians who care for them. Practicing clinicians, biomedical researchers, medical trainees, patients, and anyone with an interest in health will find unique insights in “Intention to Treat.”
January 11, 2023
NEJM This Week — January 12, 2023
Featuring articles on the progression of atrial fibrillation after cryoablation, empagliflozin in chronic kidney disease, repeat expansion in late-onset cerebellar ataxia, and the safety of inpatient health care; a review article on primary ovarian insufficiency; a case report of a man with hypokalemia and paranoia; and Perspective articles on the anchor strategy and on corporate investors in primary care. Supplement to the New England Journal of Medicine, Vol. 388, No. 2.
January 11, 2023
NEJM This Week — January 5, 2023
Featuring articles on a monoclonal antibody for early Alzheimer’s disease, risk assessment for patients with heart failure, RAS inhibition in pancreatic cancer, inhibition of mutant KRAS in colorectal cancer, and public health and the Inflation Reduction Act; a review article on new approaches to chronic hepatitis B; a Clinical Problem-Solving on a stormy heart; and Perspective articles on the fresh assault on insurance coverage mandates, on evidence over politics, and on death by ableism. Supplement to the New England Journal of Medicine, Vol. 388, No. 1.
January 4, 2023
NEJM This Week — December 29, 2022
Featuring articles on chlorthalidone in cardiovascular events, vaccines for Zaire Ebola virus disease, haloperidol for delirium in ICU patients, and reporting of emissions to achieve net-zero health care; a review article on alcohol-associated hepatitis; a case report of a man with exertional chest discomfort; and Perspective articles on understanding the key to outbreak control, on hospitals and health equity, and on engineering for grief. Supplement to the New England Journal of Medicine, Vol. 387, No. 26.
December 28, 2022
NEJM This Week — December 22, 2022
Featuring articles on surgery or endovascular therapy for limb ischemia, dupilumab in patients with eosinophilic esophagitis, an oral regimen for rifampin-resistant tuberculosis, gene therapy for ART-SCID, and recombinant ADAMTS13 in a pregnant woman with thrombotic thrombocytopenic purpura; a review article on oxygen delivery in the treatment of anemia; a case report of a woman with postpartum abdominal pain and fever; and Perspective articles on U.S. health insurance coverage and financing, on cholera in Haiti, again, and on revaluing primary care. Supplement to the New England Journal of Medicine, Vol. 387, No. 25.
December 21, 2022
NEJM AI Grand Rounds
NEJM AI Grand Rounds, hosted by Arjun (Raj) Manrai, Ph.D. and Andrew Beam, Ph.D., features informal conversations with a variety of unique experts exploring the deep issues at the intersection of artificial intelligence, machine learning, and medicine. You’ll learn how AI will change clinical practice and healthcare, how it will impact the patient experience, and about the people who are pushing for innovation. Whether you are an AI researcher or a practicing clinician, these conversations will enlighten and surprise you as we journey through this very exciting field. Produced by NEJM Group.
December 14, 2022
NEJM This Week — December 15, 2022
Featuring articles on gene therapy for dystrophic epidermolysis bullosa, glofitamab in refractory diffuse large B-cell lymphoma, talquetamab for multiple myeloma, once-weekly semaglutide in adolescents with obesity, and on click chemistry; a review article on the risks of infection in xenotransplantation; a case report of a woman with fatigue and weight gain; and Perspective articles on a step toward interoperability of health IT, on a Covid-19 milestone attained, and on the Josephine way. Supplement to the New England Journal of Medicine, Vol. 387, No. 24.
December 14, 2022
NEJM This Week — December 8, 2022
Featuring articles on therapy with tumor-infiltrating lymphocytes or ipilimumab in melanoma, biopsy method and overdiagnosis in prostate cancer, methylprednisolone for heart surgery in infants, and in utero enzyme-replacement therapy; a review article on hemochromatosis; a case report of a man with fatigue, weight loss, and pulmonary nodules; and Perspective articles on for-profit medical schools, on closing the gap in cancer genomic testing, and on deciding on her dimples. Supplement to the New England Journal of Medicine, Vol. 387, No. 23.
December 7, 2022
NEJM This Week — December 1, 2022
Featuring articles on RAS inhibition in advanced chronic kidney disease, buprenorphine versus methadone in pregnancy, iron chelation for Parkinson’s disease, training to prevent crashes in teens with ADHD, and on prolonging cellular life after hypoxic death; a review article on infantile and childhood hydrocephalus; a Clinical Problem-Solving on hiding in plain sight; and Perspective articles on the perpetual challenge of infectious diseases, on prescribing opioids for pain, on the White House Conference on Hunger, Nutrition, and Health, and on injustice disorder. Supplement to the New England Journal of Medicine, Vol. 387, No. 22.
November 30, 2022
NEJM This Week — November 24, 2022
Featuring articles on pemafibrate to reduce cardiovascular risk, on lifting universal masking in schools, defibrillation strategies for refractory ventricular fibrillation, bepirovirsen in chronic hepatitis B infection, and the IARC perspective on oral cancer prevention; a review article on climate change and vectorborne diseases; a case report of a woman with decreased vision and headache; and Perspective articles on privacy and security, on protecting care for all, and on transgender health and science denialism. Supplement to the New England Journal of Medicine, Vol. 387, No. 21.
November 23, 2022
NEJM This Week — November 17, 2022
Featuring articles on a monoclonal antibody against malaria in Mali, assessing strategies for spontaneous-breathing trials, lipoprotein(a) and cardiovascular disease, and the Covid-19 vaccine in children and adolescents in Qatar; a review article on gout; a case report of a man with progressive dyspnea, neck swelling, and a lung mass; and Perspective articles on telemedicine, on monkeypox, and on COP27 and urgent action needed for Africa and the world. Supplement to the New England Journal of Medicine, Vol. 387, No. 20.
November 16, 2022
NEJM This Week — November 10, 2022
Featuring articles on liquefied petroleum gas or biomass for cooking and effects on birth weight, early mobilization during ventilation in the ICU, oxygen-saturation targets for mechanical ventilation, protection against omicron in California prisons, and on cognitive deficits in long Covid-19; a review article on monkeypox; a case report of a woman with Covid-19 and delusions; and Perspective articles on circulating poliovirus in New York, on antiretrovirals in incarcerated populations, and on diagnostic distress. Supplement to the New England Journal of Medicine, Vol. 387, No. 19.
November 9, 2022
NEJM This Week — November 3, 2022
Featuring articles on the effect of psilocybin on treatment-resistant depression, brentuximab vedotin in pediatric Hodgkin’s lymphoma, early infusion of amino acids and neurodisability at 2 years, and the mRNA-1273 vaccine in children 6 months to 5 years of age; a review article on noninvasive respiratory support in acute respiratory failure; a Clinical Problem-Solving on a shear decline; and Perspective articles on whether it is burnout or depression, on pharmaceutical marketing revisited, and on the worst thing. Supplement to the New England Journal of Medicine, Vol. 387, No. 18.
November 2, 2022
NEJM This Week — October 27, 2022
Featuring articles on colonoscopy screening and colorectal cancer, neoadjuvant cemiplimab for locally advanced skin cancer, racial and ethnic-group differences in bystander CPR, DHA supplementation and IQ after preterm birth, and on abortion restrictions and mental health inequity; a review article on spontaneous intracerebral hemorrhage; a case report of a girl with redness of the eyes; and Perspective articles on medical malpractice law, on abortion access as a racial justice issue, on the national coverage determination for aducanumab, and on what Covid has taught the world about ethics. Supplement to the New England Journal of Medicine, Vol. 387, No. 17.
October 26, 2022
NEJM This Week — October 20, 2022
Featuring articles on two randomized trials of ruxolitinib cream for vitiligo, blood-pressure and oxygen targets in comatose patients after cardiac arrest, intermittently scanned glucose monitoring, and on recognition for integrin research; a review article on myocarditis; a case report of a man with postoperative cardiogenic shock and diffuse rash; and Perspective articles on impending relief for Medicare beneficiaries, on on- and off-ramps of oncology accelerated approval, and on an emergency room trajectory. Supplement to the New England Journal of Medicine, Vol. 387, No. 16.
October 19, 2022
NEJM This Week — October 13, 2022
Featuring articles on PCI for ischemic left ventricular dysfunction, endovascular treatment of basilar-artery occlusion, five-year outcomes of the Danish Cardiovascular Screening trial, and a report on twin boys with excessive caloric intake but low body weight; a review article on the treatment and prevention of heat-related illness; a case report of a man with heartburn, nausea, and inability to eat; and Perspective articles on access to treatment for opioid use disorder, on repealing state drug-paraphernalia laws, and on new federal incentives for diversity in trials. Supplement to the New England Journal of Medicine, Vol. 387, No. 15.
October 12, 2022
NEJM This Week — October 6, 2022
Featuring articles on cerebral embolic protection during TAVR, intravenous immune globulin in dermatomyositis, omicron-containing mRNA vaccine booster immunogenicity, an extravascular implantable cardioverter–defibrillator, the Lasker Award for discovery of circulating cell-free DNA, and on going from the eyeball test to the algorithm; a review article on drowning prevention and initial treatment; a Clinical Problem-Solving on thinking outside the heart; and Perspective articles on public carry versus public health, on intimate-partner violence after Dobbs and Bruen, and on the macro-harm of micro-geography. Supplement to the New England Journal of Medicine, Vol. 387, No. 14.
October 5, 2022
NEJM This Week — September 29, 2022
Featuring articles on a bionic pancreas in type 1 diabetes, bronchodilators in symptomatic tobacco-exposed persons, acetazolamide in acute decompensated heart failure, and a new target for CAR T cells in myeloma; a review article on gastroesophageal reflux disease; a case report of a newborn girl with hypoglycemia; and Perspective articles on the war-zone mentality, on intradermal vaccination for monkeypox, on product hopping in the drug industry, and on a hidden crisis. Supplement to the New England Journal of Medicine, Vol. 387, No. 13.
September 28, 2022
NEJM This Week — September 22, 2022
Featuring articles on glycemic outcomes of glycemia reduction, microvascular outcomes of glycemia reduction, dapagliflozin in heart failure with preserved ejection fraction, and an antisense oligonucleotide for SOD1 ALS; a review article on Burkitt’s lymphoma; a case report of a man with chronic diarrhea and autoimmune enteropathy; and Perspective articles on the law of licensure and quality regulation, on pushing back with pills, and on the seeds of ignorance. Supplement to the New England Journal of Medicine, Vol. 387, No. 12.
September 21, 2022
NEJM This Week — September 15, 2022
Featuring articles on a polypill for secondary cardiovascular prevention, anticoagulation in atrial fibrillation with rheumatic heart disease, aggressive or moderate hydration in acute pancreatitis, and enteral glutamine for burn injuries; a review article on Covid-19 vaccines; a case report of a man with headache and progressive neurologic dysfunction; and Perspective articles on protecting pregnant people from climate change, on professional civil disobedience, on closing the public health ethics gap, and on finding a new mantra. Supplement to the New England Journal of Medicine, Vol. 387, No. 11.
September 14, 2022
NEJM This Week — September 8, 2022
Featuring articles on an open-source automated insulin delivery system in type 1 diabetes, closed-loop therapy in type 1 diabetes, litifilimab for systemic lupus erythematosus, routine functional testing after PCI, metagenomic sequencing and infectious disease, and race correction and the x-ray machine; a review article on personality disorders; a case report of a man with confusion, headache, and fever; and Perspective articles on emergency department ethics in a post-Roe era, on EMTALA for pregnancy-related emergencies, and on science, competing values, and trade-offs. Supplement to the New England Journal of Medicine, Vol. 387, No. 10.
September 7, 2022
NEJM This Week — September 1, 2022
Featuring articles on FFR versus intravascular ultrasonography to guide PCI, nirmatrelvir for Covid-19 during the omicron surge, antiretroviral HIV treatment in pregnancy, regimens for drug-resistant tuberculosis, and on building Black wealth; a review article on chronic urticaria; a Clinical Problem-Solving on telescoping the diagnostic process; and Perspective articles on what Dobbs means for patients with breast cancer, on the escalating cybersecurity threat to health care, on “fertility fraud” legislation, on updated health warnings for alcohol, and on losing contact. Supplement to the New England Journal of Medicine, Vol. 387, No. 9.
August 31, 2022
NEJM This Week — August 25, 2022
Featuring articles on the clinical features of monkeypox in humans, the treatment of diabetic macular edema, ublituximab in relapsing multiple sclerosis, olokizumab for rheumatoid arthritis, and on when silence disrupts; a review article on lesions of the ovary and fallopian tube; a case report of a woman with cystic lung disease; and Perspective articles on the physician–patient relationship, on hospital care for substance use disorder, and on improving the use of FDA advisory committees. Supplement to the New England Journal of Medicine, Vol. 387, No. 8.
August 24, 2022
NEJM This Week — August 18, 2022
Featuring articles on glycemic criteria for the diagnosis of gestational diabetes, a randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19, and children with acute hepatitis of unknown cause; a review article on neuromyelitis optica spectrum disorder; a case report of a woman with headache and blurred vision; and Perspective articles on confronting health worker burnout, on tecovirimat and the treatment of monkeypox, on framing traumatic injury as a chronic condition, and on professionals as targets in the culture wars. Supplement to the New England Journal of Medicine, Vol. 387, No. 7.
August 17, 2022
NEJM This Week — August 11, 2022
Featuring articles on redirecting T cells against myeloma cells, the removal of small kidney stones and relapse, the treatment of severe alpha1-antitrypsin deficiency, and BNT162b2 protection against omicron in children; a review article on bronchiectasis; a case report of a man with perianal and penile ulcers, pain, and rash; and Perspective articles on race and ethnicity in Covid risk assessments, on understanding Covid vaccine efficacy over time, on noncompete agreements, on bringing sickle-cell treatments to sub-Saharan Africa, and on a critical shortage of iodinated contrast material. Supplement to the New England Journal of Medicine, Vol. 387, No. 6.
August 10, 2022
NEJM This Week — August 4, 2022
Featuring articles on a monoclonal antibody to prevent malaria infection, monoclonal antibody therapy in Parkinson’s disease, and dulaglutide in youths with type 2 diabetes; a review article on spina bifida; a Clinical Problem-Solving on diagnostic aspirations; and Perspective articles on building a national public health system in the U.S., on a preview of the dangerous future of abortion bans, on the end of Roe v. Wade, and on code words. Supplement to the New England Journal of Medicine, Vol. 387, No. 5.
August 3, 2022
NEJM This Week — July 28, 2022
Featuring articles on supplemental vitamin D and incident fractures, brentuximab vedotin in advanced Hodgkin’s lymphoma, litifilimab for cutaneous lupus erythematosus, genetic protection against liver disease, and on lawmakers v. the scientific realities of human reproduction; a review article on tobacco addiction; a case report of a man with hypoglycemia; and Perspective articles on the history of health law in the United States, on primary care and financial risk, and on achieving the Triple Aim for sexual and gender minorities. Supplement to the New England Journal of Medicine, Vol. 387, No. 4.
July 27, 2022
NEJM This Week — July 21, 2022
Featuring articles on tirzepatide for weight loss in adults with obesity, pembrolizumab in triple-negative breast cancer, Covid-19 vaccination in children 5 to 11 years of age, and gene therapy for hemophilia B; a review article on obesity in pregnancy; a case report of a woman with cavitary lung lesions; and Perspective articles on communicating statistics on climate change, on Medical Device User Fee reauthorization, and on grieving in a pandemic. Supplement to the New England Journal of Medicine, Vol. 387, No. 3.
July 20, 2022
NEJM This Week — July 7, 2022
Featuring articles on trastuzumab deruxtecan in HER2-low breast cancer, effects of previous infection and vaccination on symptomatic omicron infections, and a report on porcine-to-human cardiac transplantation; review articles on pulmonary embolism and on the vaccine-hesitant moment; a Clinical Problem-Solving on the young and the breathless; and Perspective articles on physicians spreading misinformation on social media, on dietary supplements and institutionalizing misinformation, and on the portal. Supplement to the New England Journal of Medicine, Vol. 387, No. 1.
July 6, 2022
NEJM This Week — June 30, 2022
Featuring articles on restricted intravenous fluid in septic shock, an oncolytic virus for pediatric pontine glioma, ibrutinib for untreated mantle-cell lymphoma, and on the potency of a KRAS silent variant; a review article on mantle-cell lymphoma; a case report of a man with vision changes; and Perspective articles on nineteen days in America, on a comprehensive Covid-19 response, on the solution shop and the production line, and on being without question. Supplement to the New England Journal of Medicine, Vol. 386, No. 26.
June 29, 2022
NEJM This Week — June 23, 2022
Featuring articles on PD-1 blockade in locally advanced rectal cancer, a vaccine against respiratory syncytial virus, a vitamin C infusion in adults with sepsis, and reducing administrative harm in medicine; a review article on Philadelphia chromosome–positive acute lymphoblastic leukemia; a case report of a woman with jaundice and chronic diarrhea; and Perspective articles on racial disparity in breast-cancer mortality, on enrollee premiums in Medicaid, on a data infrastructure for clinical trial diversity, on medicalizing the Constitution, and on unexpected closure. Supplement to the New England Journal of Medicine, Vol. 386, No. 25.
June 22, 2022
NEJM This Week — June 16, 2022
Featuring articles on circulating tumor DNA and adjuvant therapy in colon cancer, the prevention of anal cancer, Chapare hemorrhagic fever in Bolivia, immune tolerance after sequential stem-cell and kidney transplantation, and potentiating the T cell; a review article on climate change, fossil-fuel pollution, and children’s health; a case report of a woman with recurrent fractures; and Perspective articles on research to move policy, on climate change in the Supreme Court, and on medical readers and literary plague. Supplement to the New England Journal of Medicine, Vol. 386, No. 24.
June 15, 2022
NEJM This Week — June 9, 2022
Featuring articles on chronic traumatic encephalopathy in military personnel, a PDE4 inhibitor for idiopathic pulmonary fibrosis, a monoclonal-antibody combination to prevent Covid-19, natural and hybrid immunity to SARS-CoV-2, and emerging technologies in health and medicine; a review article on the diagnosis and treatment of frostbite; a case report of a boy with chest pain; and Perspective articles on a radical treatment for insulin pricing, on the tobacco wars’ lessons for the vaccination wars, on physicians as political pawns, and on the high cost of cancer drugs under Medicare Part D. Supplement to the New England Journal of Medicine, Vol. 386, No. 23.
June 8, 2022
NEJM This Week — June 2, 2022
Featuring articles on an albuterol–budesonide rescue inhaler in asthma, the efficacy of a plant-based SARS-CoV-2 vaccine, the efficacy and safety of a spike protein subunit vaccine, and neoantigen T-cell receptor gene therapy in pancreatic cancer; a review article on the uses of a GFR and albuminuria level in kidney disease; a Clinical Problem-Solving describing the after-dinner dip; and Perspective articles on navigating the loss of abortion services, on HIV prevention and the 340B Drug Pricing Program, and on the care and treatment of Black girls in America. Supplement to the New England Journal of Medicine, Vol. 386, No. 22.
June 1, 2022
NEJM This Week — May 26, 2022
WFeaturing articles on neoadjuvant chemoimmunotherapy in resectable non–small-cell lung cancer, tranexamic acid for noncardiac surgery, activation of oncogene expression by demethylating agents, efficacy of the mRNA-1273 vaccine in older children, and structural racism in the academic residency clinic; a review article on the gliflozins in the management of cardiovascular disease; a case report of a man with fevers, night sweats, and a mediastinal mass; and Perspective articles on federal action supporting overdose-prevention centers, on when naloxone isn’t enough, and on e pluribus unum. Supplement to the New England Journal of Medicine, Vol. 386, No. 21.
May 25, 2022
NEJM This Week — May 19, 2022
Featuring articles on childhood risk factors and adult cardiovascular events, results of two cases of pig-to-human kidney xenotransplantation, vaccine effectiveness against omicron in children and adolescents, the efficacy and safety of a BNT162b2 booster, catching up on REMs, and on NEJM Healer; a review article on brain tumors in children; a case report of a man with persistent cough and pulmonary opacities; and Perspective articles on reforming nursing home care, on progress toward pig-to-human xenotransplantation, and on being only halfway there with sudden infant death syndrome. Supplement to the New England Journal of Medicine, Vol. 386, No. 20.
May 18, 2022
NEJM This Week — May 5, 2022
Featuring articles on baricitinib for alopecia areata, convalescent plasma for early SARS-CoV-2 infection, efficacy of a fourth mRNA vaccine dose in Israel, ivermectin for early Covid-19, a new image for cell sorting, and metric myopia; a review article on nonspecific low back pain; a Clinical Problem-Solving on looking back; and Perspective articles on designing Cures 2.0, on real-world evidence, and on addressing misinformation on social media. Supplement to the New England Journal of Medicine, Vol. 386, No. 18.
May 4, 2022
NEJM This Week — April 28, 2022
Featuring articles on CT or coronary angiography in stable chest pain, protection against omicron by a fourth vaccine dose, a vaccine for RSV in pregnancy, nasal high-flow therapy during neonatal intubation, and reassessing quality assessment; a review article on understanding vaccine safety; a case report of a man with myalgias, fever, and bradycardia; and Perspective articles on the e-cigarette flavor debate and on breaking down the residency match rate. Supplement to the New England Journal of Medicine, Vol. 386, No. 17.
April 27, 2022
NEJM This Week — April 21, 2022
Featuring articles on restricted calories and eating times in weight loss, asthma therapy in Black and Latinx adults, ivosidenib in IDH1-mutated acute myeloid leukemia, vaccine boost effects on protection against omicron, and fighting cardiac fibrosis with CAR T cells; a review article on early-onset colorectal cancer; a case report of a woman with transient ischemic attack and mitral valve masses; and Perspective articles on a change in the leading cause of death among U.S. children, on strengthening the Medicaid Reentry Act, and on Covid-19’s devastating effect on tuberculosis care. Supplement to the New England Journal of Medicine, Vol. 386, No. 16.
April 20, 2022
NEJM This Week — April 14, 2022
Featuring articles on nirmatrelvir plus ritonavir for Covid-19, the treatment of acute Achilles’ tendon rupture, rilzabrutinib in immune thrombocytopenia, mitapivat for pyruvate kinase deficiency, and global health and the moral clarity of Paul Farmer; a review article on cancer-associated hypercalcemia; a case report of a woman with pancytopenia; and Perspective articles on fully realizing SNAP’s health benefits, on the 2022 Child Nutrition Reauthorization, and reflections on caring for the unvaccinated. Supplement to the New England Journal of Medicine, Vol. 386, No. 15.
April 13, 2022
NEJM This Week — April 7, 2022
Featuring articles on endovascular therapy for large cerebral infarction, population immunity and Covid-19 severity with the omicron variant in South Africa, tebipenem for complicated urinary tract infection, an implanted stimulator in multiple-system atrophy, U.S. medical faculty diversity over four decades, and the origins of calcific aortic stenosis; a review article on the laboratory diagnosis of Creutzfeldt–Jakob disease; a Clinical Problem-Solving describing a burning question; and Perspective articles on ten years of Choosing Wisely to reduce low-value care, on putting health and equity at the center of the climate movement, and on the wild west of checkpoint inhibitor development. Supplement to the New England Journal of Medicine, Vol. 386, No. 14.
April 6, 2022
NEJM This Week — March 31, 2022
Featuring articles on Covid-19 after vaccination and previous infection, vaccination after recovery from SARS-CoV-2 infection, mini-slings for stress incontinence in women, higher-dose primaquine for P. vivax malaria, and on how medicine is not gender-neutral; a review article on decompression sickness and arterial gas embolism; a case report of a man with marked ventricular wall thickening; and Perspective articles on restrictive state abortion bans, on when patients go to court for unproven treatments, and on epidemiology and the Faroe Islands. Supplement to the New England Journal of Medicine, Vol. 386, No. 13.
March 30, 2022
NEJM This Week — March 24, 2022
Featuring articles on a single-dose liposomal amphotericin B treatment for cryptococcal meningitis, hydrocortisone to prevent bronchopulmonary dysplasia, darolutamide in metastatic prostate cancer, trastuzumab deruxtecan for HER2-positive breast cancer, addressing vaccine inequity, and targeting gene therapy to muscle; a review article on managing glycemia in children with type 1 diabetes; a case report of a woman with fever, myalgias, diarrhea, and cough; and Perspective articles on digital inclusion as health care, on a new way to contain unaffordable medication costs, and on an NPO. Supplement to the New England Journal of Medicine, Vol. 386, No. 12.
March 23, 2022
NEJM This Week — March 10, 2022
Featuring articles on shorter-course TB treatment in children, thyroidectomy without radioiodine, Covid-19 vaccine effectiveness in North Carolina, ribociclib in hormone receptor–positive breast cancer, the effects of boosters after Ad26.COV2.S vaccination, and on tumors and T cells; a review article on extracorporeal kidney-replacement therapy for acute kidney injury; a case report of a woman with depression, recurrent falls, and inability to care for herself; and Perspective articles on step therapy’s balancing act, on coverage of transvenous pulmonary embolectomy, and on the catfish king. Supplement to the New England Journal of Medicine, Vol. 386, No. 10.
March 9, 2022
NEJM This Week — March 3, 2022
Featuring articles on a balanced multielectrolyte solution versus saline in critically ill adults, troponin I after cardiac surgery and 30-day mortality, nirsevimab for prevention of RSV in infants, a final analysis of single-dose Ad26.COV2.S, and melioidosis and aromatherapy; a review article on chronic pancreatitis; a Clinical Problem-Solving on craving answers; and Perspective articles on U.S. public health law, on oral health for all, and on holding the baby. Supplement to the New England Journal of Medicine, Vol. 386, No. 9.
March 2, 2022
NEJM This Week — February 24, 2022
Featuring articles on the effectiveness of the BNT162b2 vaccine in adolescents, the treatment of epileptiform activity after cardiac arrest, mechanisms of resistance to noncovalent BTK inhibitors, Covid-19 vaccination and delta transmission, mortality from congenital Zika syndrome in Brazil, and wound healing and stem cells; a review article on reassessing human adipose tissue; a case report of a man with fatigue, weight loss, and hyperglycemia; and Perspective articles on state restrictions on mifepristone access, on abortion training in medical education, and on stabilizing health care’s share of the GDP. Supplement to the New England Journal of Medicine, Vol. 386, No. 8.
February 23, 2022
NEJM This Week — February 17, 2022
Featuring articles on LentiGlobin for sickle cell disease, tisagenlecleucel in aggressive B-cell lymphoma, axi-cel for relapsed or refractory large B-cell lymphoma, and EDP-938 to treat respiratory syncytial virus; a review article on electroconvulsive therapy; a case report of a woman with rapidly progressive weakness in the right arm and recurrent falls; and Perspective articles on health care safety during the pandemic and beyond, on inherited patients taking opioids for chronic pain, and on home help. Supplement to the New England Journal of Medicine, Vol. 386, No. 7.
February 16, 2022
NEJM This Week — February 10, 2022
Featuring articles on molnupiravir for outpatient treatment of Covid-19, cemented or uncemented hemiarthroplasty for hip fracture, efficacy of the NVX-CoV2373 vaccine against Covid-19, PD-1 inhibition in relapsed cervical cancer, pembrolizumab for triple-negative breast cancer, and a pernicious cycle affecting premalignant stem cells; a review article on marginal-zone lymphomas; a case report of a man with bilateral hearing loss and eye redness; and Perspective articles on racial biology and medical misconceptions, on developing new models for health, and on roulette. Supplement to the New England Journal of Medicine, Vol. 386, No. 6.
February 9, 2022
NEJM This Week — February 3, 2022
Featuring articles on gene therapy for β-thalassemia, mosquito nets and survival to adulthood in Tanzania, lenvatinib plus pembrolizumab for advanced endometrial cancer, and immune checkpoint therapy in esophageal cancer; a review article on fever of unknown origin; a Clinical Problem-Solving on the calm before the storm; and Perspective articles on using economics to inform public health policy, on automatic insurance policies, and on the care that was needed.Supplement to the New England Journal of Medicine, Vol. 386, No. 5.
February 2, 2022
NEJM This Week — January 27, 2022
Featuring articles on remdesivir for prevention of Covid-19 progression, cardiovascular and cancer risk with tofacitinib, tricuspid repair in mitral-valve surgery, duration of Covid-19 vaccine protection in the U.K., polatuzumab vedotin in diffuse large B-cell lymphoma, and anti-idiotype antibodies in SARS-CoV-2; a review article on medical conditions and high-altitude travel; a case report of a boy with fever, joint pain, and abdominal cramping; and Perspective articles on universal coronavirus vaccines, on transparency and the doctor–patient relationship, and on “Please don’t keep me”. Supplement to the New England Journal of Medicine, Vol. 386, No. 4.
January 26, 2022
NEJM This Week — January 20, 2022
Featuring articles on a randomized closed-loop trial in very young children with diabetes, microbiome therapy for C. difficile infection, secondary prophylaxis for latent rheumatic heart disease, targeting mutant HER2 in non–small-cell lung cancer, urinary sodium and potassium and cardiovascular risk, and on aesthetic distance and empathy; a review article on rapid diagnostic testing for SARS-CoV-2; a case report of a man with a recurrent left pleural effusion; and Perspective articles on research participation and diversity. Supplement to the New England Journal of Medicine, Vol. 386, No. 3.
January 19, 2022
NEJM This Week — January 13, 2022
We discuss the latest in medical research and ideas.
January 12, 2022
Rapid Diagnostic Testing for SARS-CoV-2 by P.K. Drain
A 38-year-old woman with type 2 diabetes has a telemedicine visit after learning that a person with whom she had close contact at an indoor wedding 3 days earlier has tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The woman reports that she is asymptomatic and received a second vaccination against SARS-CoV-2 approximately 9 months ago but has not received a booster vaccination. She attended the wedding with her husband, who has also received two vaccinations, and her two unvaccinated children, who are 5 and 8 years of age. Her husband had mild nasal congestion and a cough the evening before her appointment. She had previously purchased rapid diagnostic tests that received emergency use authorization from the Food and Drug Administration for home-based SARS-CoV-2 testing and wonders whether using these tests would be appropriate. What would you advise? Full-text recordings of Clinical Practice articles may be found at NEJM.org.
January 12, 2022
NEJM This Week — January 6, 2022
Featuring articles on eltrombopag in severe aplastic anemia, nivolumab plus LAG-3 blockade in melanoma, the BNT162b2 vaccine against Covid-19 in 5-to-11-year-olds, azithromycin for yaws eradication, and abortion outcomes with unrestricted mifepristone; a review article on snake envenomation; a Clinical Problem-Solving on being confused about confusion; and Perspective articles on the patchwork U.S. public health system, on obstacles to physicians’ emotional health, and on the doctor’s oldest tool. Supplement to the New England Journal of Medicine, Vol. 386, No. 1.
January 5, 2022
NEJM This Week — December 30, 2021
Featuring articles on chlorthalidone for hypertension in advanced chronic kidney disease, ticagrelor versus clopidogrel in stroke or transient ischemic attack, dolutegravir in children with HIV-1 infection, angiography after out-of-hospital cardiac arrest, and the 2021 Nobel Prize in Chemistry; a review article on the determination of brain death; a case report of a boy with transient weakness, facial droop, and slurred speech; and Perspective articles on whether we should include race or ethnicity at the beginning of clinical case presentations, on calling out aversive racism in academic medicine, on closing the gender pay gap in medicine, and on trust, faith, and Covid. Supplement to the New England Journal of Medicine, Vol. 385, No. 27.
December 29, 2021
NEJM This Week — December 23, 2021
Featuring articles on the effects of a Covid-19 vaccine booster, spesolimab for generalized pustular psoriasis, decentralized molecular testing for tuberculosis, and consultative medicine; a review article on immune and genome engineering as the future of transplantable tissue; a case report of a woman with respiratory failure and altered mental status; and Perspective articles on clinical care and Amazon, on Covid-19 vaccination in American Indians and Alaska Natives, on tobacco-free nicotine, and on a divisive ruling on devices. Supplement to the New England Journal of Medicine, Vol. 385, No. 26.
December 22, 2021
NEJM This Week — December 16, 2021
Featuring articles on daprodustat in patients undergoing dialysis and in those not undergoing dialysis, chemotherapy in node-positive breast cancer, a phase 3 trial of the ChAdOx1 nCoV-19 vaccine, vaccine effectiveness among U.S. health care personnel, and a hot and tactile Nobel Prize; a review article on pulmonary arterial hypertension; a case report of a woman with abdominal pain, weight loss, and memory impairment; and Perspective articles on a failure to disseminate transformative science, on E66.01 and our culture of shame, and on Ms. Omega One. Supplement to the New England Journal of Medicine, Vol. 385, No. 25.
December 15, 2021
NEJM This Week — December 9, 2021
Featuring articles on tapinarof cream for psoriasis, dupilumab in children with asthma, the mRNA-1273 vaccine in adolescents, cardiovascular events with finerenone in kidney disease and type 2 diabetes, waning vaccine protection against SARS-CoV-2, and transgenic epidermis in junctional epidermolysis bullosa; a review article on latent tuberculosis infection; a case report of a man with fevers, fatigue, arthralgias, a mouth ulcer, and a rash; and Perspective articles on Covid-19 and the safety net and on inequitable access to hospital care. Supplement to the New England Journal of Medicine, Vol. 385, No. 24.
December 8, 2021
NEJM This Week — December 2, 2021
Featuring articles on debulking surgery in relapsed ovarian cancer, myocarditis after Covid-19 mRNA vaccine, edoxaban for atrial fibrillation with TAVR, milvexian for the prevention of venous thromboembolism, REGEN-COV in outpatients with acute SARS-CoV-2 infection, and a font of protein structures; a review article on spontaneous intracranial hypotension; a Clinical Problem-Solving describing a “fluid” diagnosis; and Perspective articles on using policy tools to improve population health, on decarbonizing the U.S. health sector, and on the web we weave. Supplement to the New England Journal of Medicine, Vol. 385, No. 23.
December 1, 2021
NEJM This Week — November 25, 2021
Featuring articles on spinal or general anesthesia for hip surgery, HIF-2α inhibition in von Hippel–Lindau disease, live birth after genetic testing for aneuploidy, belzutifan in the Pacak–Zhuang syndrome, and on responsible innovation in reproductive medicine; a review article on osteosarcoma; a case report of a man with pain and erythema of the left hand; and Perspective articles on why aducanumab is priced at $56,000 per patient, on Medicare coverage of aducanumab, and on the little things. Supplement to the New England Journal of Medicine, Vol. 385, No. 22.
November 24, 2021
NEJM This Week — November 18, 2021
Featuring articles on hematopoietic gene therapy for Hurler syndrome, sotrovimab for early Covid-19, convalescent plasma for high-risk Covid-19, gene therapy for hemophilia A, parathyroid hormone resistance, and on hunger and mood; a review article on salt handling and blood pressure; a case report of a woman with pain in the left upper quadrant and hypoxemia; and Perspective articles on regulating drug prices while increasing innovation and on the drug-pricing debate redux. Supplement to the New England Journal of Medicine, Vol. 385, No. 21.
November 17, 2021
NEJM This Week — November 11, 2021
Featuring articles on alteplase followed by endovascular treatment for stroke, sacubitril–valsartan in acute myocardial infarction, pembrolizumab in advanced cervical cancer, genome sequencing in health care, and screening for cervical cancer; a review article on pollution and the heart; a case report of a man with altered mental status and new onset of seizures; and Perspective articles on the future of SARS-CoV-2 vaccination and on when women and children made the policy agenda. Supplement to the New England Journal of Medicine, Vol. 385, No. 20.
November 10, 2021
NEJM This Week — November 4, 2021
Featuring articles on new equations for estimating GFR without race, BNT162b2 vaccine at 6 months of follow-up, efficacy of the mRNA-1273 vaccine at the end of the blinded phase, providing grist for antitumor immunity; and continuity, fragmentation, and Adam Smith; a review article on peritoneal dialysis; a Clinical Problem-Solving describing a copycat; and Perspective articles on applying a subpopulation lens to population health, on racial and ethnic diversity at medical schools, and on none of the above. Supplement to the New England Journal of Medicine, Vol. 385, No. 19.
November 3, 2021
NEJM This Week — October 28, 2021
Featuring articles on dual antiplatelet therapy in patients at high bleeding risk, itepekimab in moderate-to-severe asthma, risankizumab in severe asthma, and vaccine-induced thrombocytopenia and thrombosis; a review article on abdominal aortic aneurysms; a case report of a man with painful mouth ulcers; and Perspective articles on uncomfortable truths, on the 2021 reauthorization of the Child Abuse Prevention and Treatment Act, and on a therapeutic relationship. Supplement to the New England Journal of Medicine, Vol. 385, No. 18.
October 27, 2021
NEJM This Week — October 21, 2021
Featuring articles on a randomized trial of a pan-PPAR agonist in NASH, outcomes in nonalcoholic fatty liver disease, the AQP1 promoter variant and peritoneal dialysis, obesity in childhood and GNAS mutations, and optogenetics recognized through the Lasker Award; a review article on point-of-care ultrasonography; a case report of a girl with swelling of the jaw and hypercalcemia; and Perspective articles on blood donation by gay and bisexual men, on the case for wage equity for essential health care workers, and on peak moments. Supplement to the New England Journal of Medicine, Vol. 385, No. 17.
October 20, 2021
NEJM This Week — October 14, 2021
Featuring articles on empagliflozin in heart failure with preserved ejection fraction, oxytocin in autism spectrum disorder, breakthrough Covid-19 in health care workers, a cell-culture influenza vaccine, and data in crisis; a review article on aspergillus infections; a case report of a man with sore throat, epistaxis, and oropharyngeal petechiae; and Perspective articles on vigilante injustice, eviction and the necessary conditions for health, the drug-dosing conundrum in oncology, and on a good death. Supplement to the New England Journal of Medicine, Vol. 385, No. 16.
October 13, 2021
NEJM This Week — October 7, 2021
Featuring articles on Covid-19 vaccine effectiveness in medical settings, immediate vs. delayed drainage for infected necrotizing pancreatitis, bamlanivimab plus etesevimab for Covid-19, third dose of Covid-19 vaccine in Israel, broadly neutralizing antibodies against all coronaviruses, striving for diversity in research studies, and mRNA vaccine research and the Lasker–DeBakey Award; a review article on autoimmune hemolytic anemias; a Clinical Problem-Solving on a woman with throat pain; and Perspective articles on methods of public health research, on the No Surprises Act and informed financial consent, and on integrating research into community practice. Supplement to the New England Journal of Medicine, Vol. 385, No. 15.
October 6, 2021
NEJM This Week — September 30, 2021
Featuring articles on antidepressants in primary care practice, intensive blood-pressure control in older patients, ozanimod for ulcerative colitis, and Wnt proteins and structural birth defects; a review article on newer biologic and small-molecule therapies for IBD; a case report of a man with recurrent head and neck pain; and Perspective articles on moving toward a new era for the Indian Health System, on marking the 40th anniversary of the AIDS epidemic, and on cool water. Supplement to the New England Journal of Medicine, Vol. 385, No. 14.
September 29, 2021
NEJM This Week — September 23, 2021
Featuring articles on artemisinin-resistant malaria in Africa, safety and efficacy of the NVX-CoV2373 vaccine, subcutaneous antibody combination and Covid-19, tebentafusp for uveal melanoma, reenergizing HCV vaccine development, and HER2-mutated breast cancer and overcoming drug resistance; a review article on mesothelioma; a case report of a boy with fever and developmental regression; and Perspective articles on public health law after Covid-19 and on revitalizing the U.S. primary care infrastructure. Supplement to the New England Journal of Medicine, Vol. 385, No. 13.
September 22, 2021
NEJM This Week — September 16, 2021
Featuring articles on salt substitution and cardiovascular events, safety of the BNT162b2 mRNA Covid-19 vaccine, lutetium-177 in prostate cancer, typhoid vaccine in Malawian children, and a call for emergency action on the climate crisis; a review article on the treatment of acute appendicitis; a case report of a woman with Covid-19 and suicidal ideation; and Perspective articles on public option plans and on the treatment of older adults with cancer. Supplement to the New England Journal of Medicine, Vol. 385, No. 12.
September 15, 2021
NEJM This Week — September 9, 2021
Featuring articles on a trial of mobile stroke units, iron interventions in infants in rural Bangladesh, somatic mutations in sporadic cerebral cavernous malformations, malaria vaccination with or without chemoprevention, and sensible but very cool advances in protein chemistry; a review article on the challenges of sarcoidosis and its management; a case report of an adolescent seeking HIV prophylaxis; and Perspective articles on SARS-CoV-2 human challenge studies, on supporting value-based health care, and on environmental racism and climate change. Supplement to the New England Journal of Medicine, Vol. 385, No. 11.
September 8, 2021
NEJM This Week — September 2, 2021
Featuring articles on the inactivated SARS-CoV-2 vaccine in Chile, mycophenolate mofetil for immune thrombocytopenia, cardiovascular and renal outcomes with efpeglenatide, MRI-directed prostate biopsies, and natural killer cells in defense against HPV; a review article on chronic meningitis; a Clinical Problem-Solving describing inadequate support; and Perspective articles on population health and human rights, on Covid-induced changes in health care delivery, and on paying for digital health care. Supplement to the New England Journal of Medicine, Vol. 385, No. 10.
September 1, 2021
NEJM This Week — August 26, 2021
Featuring articles on therapeutic anticoagulation in hospitalized patients with Covid-19, anticoagulation in moderate Covid-19, a monoclonal antibody for malaria prevention, triple therapy for cystic fibrosis, modeling heart development, and remembering past lessons about structural racism; a review article on heparin resistance; a case report of a man with relapsed acute myeloid leukemia; and Perspective articles on revisiting the FDA approval of aducanumab, on controversy and progress in Alzheimer’s disease, and on a pink salwar. Supplement to the New England Journal of Medicine, Vol. 385, No. 9.
August 25, 2021
NEJM This Week — August 19, 2021
Featuring articles on adjuvant pembrolizumab in renal-cell carcinoma, oral atogepant for migraine prevention, male infertility and small noncoding RNAs, and adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia; a review article on long-term survival after kidney transplantation; a case report of a man with fatigue and leg swelling; and Perspective articles on ending the campaign to undo the ACA in the courts, on Medicare Physician Payment Reform, and on the Covid-19 infodemic. Supplement to the New England Journal of Medicine, Vol. 385, No. 8.
August 18, 2021
NEJM This Week — August 12, 2021
Featuring articles on vaccine effectiveness against the delta Covid-19 variant, injectable cabotegravir for prevention of HIV infection, antibody to factor XI after total knee replacement, year 1 of the Bundled Payments for Care Improvement–Advanced payment model, and on a new dimension in the RNA world; a review article on signature cytokines and immune-mediated inflammatory diseases; a case report of a woman with fever, sore throat, and confusion; and Perspective articles on confronting long-haul Covid, on the criminalization of gender-affirming care, and on when low tech wins. Supplement to the New England Journal of Medicine, Vol. 385, No. 7.
August 11, 2021
NEJM This Week — August 5, 2021
Featuring articles on CRISPR-Cas9 disruption of TTR in transthyretin amyloidosis, tirzepatide versus semaglutide for type 2 diabetes, milrinone or dobutamine for cardiogenic shock, decompression versus fusion for lumbar spondylolisthesis, and SARS-CoV-2 and immunosuppression; a review article on age-related macular degeneration; a Clinical Problem-Solving on turning purple with pain; and Perspective articles on the complementarity of public health and medicine, on contact tracing for Covid-19, on supporting trainees from groups that are underrepresented in medicine, and on establishing medical civil rights. Supplement to the New England Journal of Medicine, Vol. 385, No. 6.
August 4, 2021
NEJM This Week — July 29, 2021
Featuring articles on the duration of adjuvant therapy in breast cancer, tofacitinib for Covid-19 pneumonia, complications in youth-onset type 2 diabetes, a small-molecule SMN2 modifier in type 1 spinal muscular atrophy, a hyperimmune globulin to prevent congenital cytomegalovirus, and scarless wound healing; a review article on depression in adolescents; a case report of a woman with bloody stools and thrombocytopenia; and Perspective articles on from crime to care, on health care budgets for rural providers, on identifying and tracking SARS-CoV-2 variants, and on a child’s loss. Supplement to the New England Journal of Medicine, Vol. 385, No. 5.
July 28, 2021
NEJM This Week — July 22, 2021
Featuring articles on PCI guided by FFR or angiography for STEMI, pimavanserin for dementia-associated psychosis, Covid-19 prevention and attenuation with mRNA vaccines, second-line treatment of HIV-1 infection in Sub-Saharan Africa, and racial inequality in prescription opioid receipt; a review article on substance use among men who have sex with men; a case report of a woman with cognitive impairment, headache, and memory loss; and Perspective articles on medical–financial partnerships, on Virchow at 200 and Lown at 100, and on one hundred years of insulin for some. Supplement to the New England Journal of Medicine, Vol. 385, No. 4.
July 21, 2021
NEJM This Week — July 15, 2021
Featuring articles on rehabilitation after hospitalization for heart failure, detecting speech in a paralyzed person with anarthria, ruxolitinib for chronic graft-versus-host disease, BNT162b2 vaccination against Covid-19 in 12-to-15-year-old adolescents, and inhibiting PD-L1 in hepatocellular carcinoma; a review article on the initial management of seizure in adults; a case report of a pregnant woman with fever, abdominal pain, and headache; and Perspective articles on averting future vaccine inequity, on scaling up Covid-19 vaccination in Africa, and on a medical home. Supplement to the New England Journal of Medicine, Vol. 385, No. 3.
July 14, 2021
NEJM This Week — July 8, 2021
Featuring articles on fetal surgery for severe left diaphragmatic hernia and for moderate left diaphragmatic hernia, comparisons of interleukin-17 inhibitors in psoriasis, and SARS-CoV-2 variants and vaccines; a review article on hematuria in adults; a case report of a man with ataxia; and Perspective articles on addressing vaccine hesitancy in BIPOC communities, on Covid-19 vaccine follow-through, and on the CT scan after 50 years. Supplement to the New England Journal of Medicine, Vol. 385, No. 2.
July 7, 2021
NEJM This Week — July 1, 2021
Featuring articles on the treatment of multisystem inflammatory syndrome in children, a transglutaminase 2 inhibitor for celiac disease, daratumumab in light-chain amyloidosis, embryo selection in vitro, and clonal peregrinations in the placenta; a review article on cerebral venous thrombosis; a Clinical Problem-Solving on a brewing back pain; and Perspective articles on the learning health system, on whether learning is worth the trouble, and on Covid-19 and the investigator pipeline. Supplement to the New England Journal of Medicine, Vol. 385, No. 1.
June 30, 2021
NEJM This Week — June 17, 2021
Featuring articles on mRNA Covid-19 vaccine safety in pregnant persons, hypothermia or normothermia after cardiac arrest, rituximab vs. mycophenolate mofetil for pemphigus, sudden cardiac death in persons with HIV, and SARS-CoV-2 vaccine design; a review article on infections in patients with cirrhosis; a case report of a man with cough, fever, and shortness of breath; and Perspective articles on promoting equity for women in medicine, on misogyny in medicine, and on escaping the labyrinth. Supplement to the New England Journal of Medicine, Vol. 384, No. 24.
June 16, 2021
NEJM This Week — June 10, 2021
Featuring articles on wolbachia-infected mosquito deployments for dengue, Ad26.COV2.S vaccine efficacy against Covid-19, thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination, variant SARS-CoV-2 infection after vaccination, and on diabetes treatment and control in U.S. adults from 1999 to 2018; a review article on recent advances in the treatment of melanoma; a case report of a woman with pain, swelling, and ecchymosis of the left arm; and Perspective articles on HIPAA at 25, on HIPAA and the leak of “deidentified” EHR data, and on what did I sign up for? Supplement to the New England Journal of Medicine, Vol. 384, No. 23.
June 9, 2021
NEJM This Week — June 3, 2021
Featuring articles on left atrial appendage occlusion during cardiac surgery, thrombosis after ChAdOx1 nCoV-19 vaccination, adjuvant nivolumab for invasive urothelial carcinoma, a meningococcal X vaccine in Mali, and irritable bowel syndrome and immunity; a review article on HIV infection; a Clinical Problem-Solving describing a hypertensive heartbreak; and Perspective articles on women’s health; on institutional problems, individual solutions; and on merging mortalities. Supplement to the New England Journal of Medicine, Vol. 384, No. 22.
June 2, 2021
NEJM This Week — May 27, 2021
Featuring articles on aspirin dosing in cardiovascular disease, antibiotic therapy for prosthetic joint infection, gene therapy for adenosine deaminase deficiency, a novel microRNA in acute myocarditis, and immediate “kangaroo mother care” of low-birth-weight infants; a review article on somatic mutations in “benign” disease; a case report of a woman with abdominal pain and aortic dilatation; and Perspective articles on the “legal epidemiology” of pandemic control, on a hidden opportunity, and on dilemmas of double consciousness. Supplement to the New England Journal of Medicine, Vol. 384, No. 21.
May 26, 2021
NEJM This Week — May 20, 2021
Featuring articles on efficacy of the ChAdOx1 nCoV-19 vaccine against the B.1.351 variant, NVX-CoV2373 vaccine efficacy against B.1.351 in South Africa, endovascular therapy for basilar-artery stroke, intensive or standard blood-pressure control, and on gene editing for congenital neutropenia; a review article on monoclonal gammopathy of renal significance; a case report of a woman with nausea, diarrhea, and acute kidney failure; and Perspective articles on minority tax reform, on training future health justice leaders, and on finding a way to break through the fog. Supplement to the New England Journal of Medicine, Vol. 384, No. 20.
May 19, 2021
NEJM This Week — May 6, 2021
Featuring articles on a trial of an antibody to amyloid in Alzheimer’s disease, short-course treatment of tuberculosis, weight loss maintenance with exercise and liraglutide, dexamethasone and surgical-site infection, a fountain of youthful retinal ganglion cells, and decoupling crisis response from policing; a review article on gastric emptying abnormalities in diabetes; a Clinical Problem-Solving on the inside and out; and Perspective articles on understanding and mitigating health inequities, on designing an independent public health agency, and on losing touch. Supplement to the New England Journal of Medicine, Vol. 384, No. 18.
May 5, 2021
NEJM This Week — April 29, 2021
Featuring articles on vadadustat in non–dialysis-dependent chronic kidney disease, vadadustat for anemia in patients undergoing dialysis, oncolytic HSV therapy in pediatric glioma, blood-loss prevention after cesarean delivery, and diversity of the national medical student body; a review article on postpartum hemorrhage; a case report of a newborn girl with a neck mass; and Perspective articles on Australian firearm regulation at 25, on vaccination plus decarceration, and on the Zoom family meeting. Supplement to the New England Journal of Medicine, Vol. 384, No. 17.
April 28, 2021
NEJM This Week — April 22, 2021
Featuring articles on interleukin-6 receptor blockade in severe Covid-19, tocilizumab in severe Covid-19 pneumonia, a microbiota-directed food supplement for malnutrition, sacituzumab govitecan in triple-negative breast cancer, and fighting SARS-CoV-2 with nanobodies; a review article on adrenal incidentaloma; a case report of a man with a rash on the scalp and face; and Perspective articles on advancing President Biden’s equity agenda, on encouraging acceptance of Covid-19 vaccines, and on Nanima. Supplement to the New England Journal of Medicine, Vol. 384, No. 16.
April 21, 2021
NEJM This Week — April 15, 2021
Featuring articles on hypothermic machine perfusion in liver transplantation, a trial of psilocybin for depression, the effectiveness of the BNT162b2 mRNA vaccine in Israel, sedation in mechanically ventilated adults with sepsis, and soothing science skepticism; a review article on glomerular filtration and albuminuria; a case report of a woman with fever, flank pain, and inguinal lymphadenopathy; and Perspective articles on new legislation on out-of-network billing, on remote patient monitoring, and on remembering the Freedom House Ambulance Service. Supplement to the New England Journal of Medicine, Vol. 384, No. 15.
April 14, 2021
NEJM This Week — April 8, 2021
Featuring articles on lenvatinib plus pembrolizumab in renal cell cancer, oxygenation targets for acute respiratory failure, cardiovascular risk and glycemic index, sutimlimab in cold agglutinin disease, extending life span in a mouse model of progeria, and overcoming Covid vaccine hesitancy; a review article on vestibular schwannomas; a case report of a man with depressed mood, unsteady gait, and urinary incontinence; and Perspective articles on combatting vaccine nationalism, on vancomycin infusion reaction, and on minds in crisis in a city in crisis. Supplement to the New England Journal of Medicine, Vol. 384, No. 14.
April 7, 2021
NEJM This Week — April 1, 2021
Featuring articles on adjuvant nivolumab in esophageal cancer, sotatercept for pulmonary arterial hypertension, lumasiran for primary hyperoxaluria type 1, upadacitinib for psoriatic arthritis, and an Ebola relapse leading to transmission; a review article on glucose-lowering drugs to prevent cardiovascular disease; a Clinical Problem-Solving on stalking the diagnosis; and Perspective articles on emerging infectious diseases, on ensuring that LGBTQI+ people count, and on the first Black woman to earn a medical degree in the United States. Supplement to the New England Journal of Medicine, Vol. 384, No. 13.
March 31, 2021
NEJM This Week — March 25, 2021
Featuring articles on the efficacy of the ALVAC–gp120 HIV vaccine, a JAK inhibitor or interleukin-4 blockade for atopic dermatitis, semaglutide for nonalcoholic steatohepatitis, enfortumab vedotin for relapse of urothelial cancer, the link between cancer and obesity, and embracing genetic diversity to improve Black health; a review article on atopic dermatitis; a case report of a boy with headache, abdominal pain, and hypertension; and Perspective articles on progress in vaccine technology, on addressing workforce diversity, and on the good fit. Supplement to the New England Journal of Medicine, Vol. 384, No. 12.
March 24, 2021
NEJM This Week — March 18, 2021
Featuring articles on once-weekly semaglutide in adults with overweight or obesity, neutralizing antibodies to prevent HIV-1 infection, passive immunotherapy in patients with Covid-19, inhibition of C3 in paroxysmal nocturnal hemoglobinuria, and the political nature of sex; a review article on extrahepatic manifestations of chronic HCV infection; a case report of a woman with cholangiocarcinoma; and Perspective articles on private equity and physician medical practices, on the good doctor, and on the intern. Supplement to the New England Journal of Medicine, Vol. 384, No. 11.
March 17, 2021
NEJM This Week — March 11, 2021
Featuring articles on a randomized trial of gestational diabetes screening, a neutralizing monoclonal antibody for hospitalized patients with Covid-19, risdiplam in type 1 spinal muscular atrophy, genome sequencing in myeloid cancers, a cautionary note about round spermatid injection, and supplying insulin while evading immunity; a review article on epistaxis; a case report of a man with shock, multiple organ failure, and rash; and Perspective articles on supporting clinical trainees with disabilities, on doctors with mental illness and structural barriers to disclosure, and on being breathless. Supplement to the New England Journal of Medicine, Vol. 384, No. 10.
March 10, 2021
NEJM This Week — March 4, 2021
Featuring articles on baricitinib plus remdesivir for adults with Covid-19, albumin infusions in patients with cirrhosis, a trial of terlipressin for hepatorenal syndrome, nivolumab plus cabozantinib in renal-cell carcinoma, and on misrepresenting race; a review article on diffuse large B-cell lymphoma; a Clinical Problem-Solving describing a treacherous course; and Perspective articles on conquering atherosclerotic cardiovascular disease, on reform of payment for primary care, and on being without sanctuary. Supplement to the New England Journal of Medicine, Vol. 384, No. 9.
March 3, 2021
NEJM This Week — February 25, 2021
Featuring articles on dexamethasone treatment in Covid-19, BCMA-specific CAR T cells in refractory myeloma, a cholinergic agonist and peripheral antagonist for schizophrenia, the Center for Medicare and Medicaid Innovation at 10 years, inflammation in ALS, and how structural racism works; a review article on β-thalassemias; a case report of a man with eye pain and decreased vision; and Perspective articles on last-mile logistics of Covid-19 vaccination, on telemedicine and medical licensure, and on the inequity of isolation. Supplement to the New England Journal of Medicine, Vol. 384, No. 8.
February 24, 2021
NEJM This Week — February 18, 2021
Featuring articles on a C5a receptor inhibitor for ANCA vasculitis, convalescent plasma in Covid-19, relugolix combination therapy for uterine fibroid symptoms, and promoting Covid-19 vaccination in the United States; a review article on maintaining safety with SARS-CoV-2 vaccines; a case report of a man with delirium and renal insufficiency; and Perspective articles on vaccinating children against Covid-19 and on the FDA’s experience with Covid-19 antibody tests. Supplement to the New England Journal of Medicine, Vol. 384, No. 7.
February 17, 2021
NEJM This Week — February 11, 2021
Featuring articles on repurposed antiviral drugs for Covid-19, a tirbanibulin ointment for actinic keratosis, a vestibular implant for bilateral vestibular hypofunction, antibodies and SARS-CoV-2 infection in health workers, a randomized trial of an HCV vaccine regimen, and regulatory T cells in multiple sclerosis; a review article on circadian mechanisms in medicine; a case report of a woman with dyspnea on exertion and abnormal findings on chest imaging; and Perspective articles on the future of drug-pricing transparency, on a shared evaluation platform for medical training, and on lessons from the Irish wake. Supplement to the New England Journal of Medicine, Vol. 384, No. 6.
February 10, 2021
NEJM This Week — February 4, 2021
Featuring articles on an mRNA-1273 vaccine to prevent Covid-19, a trial of hydroxychloroquine to prevent Covid-19, breast cancer risk revisited, much ado about certain breast cancer genes, and race and genetic ancestry in medicine; a review article on antithrombotic therapy after acute coronary syndromes; a Clinical Problem-Solving describing the hunt for a diagnosis; and Perspective articles on vaccine innovations, on the search of a better equation, and on learning about end-of-life care from Grandpa. Supplement to the New England Journal of Medicine, Vol. 384, No. 5.
February 3, 2021
NEJM This Week — January 28, 2021
Featuring articles on cryoablation for atrial fibrillation, inhaled treprostinil in interstitial lung disease, a levonorgestrel vs. copper IUD for emergency contraception, the return of cardiac activity after withdrawal of life support, and antigen presentation by B cells in multiple sclerosis; a review article on atrial fibrillation; a case report of a man with transient vision loss; and Perspective articles on reimagining infective endocarditis care amid the opioid epidemic, on a medical “ecology of attention”, and on the surgeon and the mother. Supplement to the New England Journal of Medicine, Vol. 384, No. 4.
January 27, 2021
NEJM This Week — January 21, 2021
Featuring articles on inhibiting BCL11A to treat sickle cell disease and β-thalassemia, a polypill with or without aspirin in primary prevention, and neutralizing-antibody therapy in Covid-19; a review article on the effects of infection on natural immunity; a case report of a pregnant woman with ventricular tachycardia and shock; and Perspective articles on testing in a pandemic, on the Supreme Court and pandemic controls, and on incarceration and social death. Supplement to the New England Journal of Medicine, Vol. 384, No. 3.
January 20, 2021
NEJM This Week — January 14, 2021
Featuring articles on omecamtiv mecarbil in systolic heart failure, sotagliflozin in diabetes with heart failure, sotagliflozin for heart failure in diabetes and kidney disease, bupropion and naltrexone for methamphetamine use, and procuring oligodendrocytes after spinal cord injury; a review article on Ewing’s sarcoma; a case report of a woman with lethargy and altered mental status; and Perspective articles on the Purdue Pharma opioid settlement, on drug-coated devices for peripheral arterial disease, and on the doctor as street-level bureaucrat. Supplement to the New England Journal of Medicine, Vol. 384, No. 2.
January 13, 2021
NEJM This Week — January 7, 2021
Featuring articles on sitagliptin for prevention of acute GVHD, tocilizumab in Covid-19 pneumonia, rilonacept in recurrent pericarditis, vaginal mother-to-child transmission of cancer, and on whether the melanoma epidemic is real; a review article on osteoarthritis of the knee; a Clinical Problem-Solving on breathing for two; and Perspective articles on human molecular genetics and genomics, on Covid-19 and the undocumented Latinx community, and on the stress of Bayesian medicine. Supplement to the New England Journal of Medicine, Vol. 384, No. 1.
January 6, 2021
NEJM This Week — December 31, 2020
Featuring articles on the safety and efficacy of an RNA-based SARS-CoV-2 vaccine, dexamethasone in chronic subdural hematoma, sleuthing out a severe adult inflammatory disorder, hemoglobin transfusion thresholds in infants, and vaccinating against SARS-CoV-2; a review article on the pathophysiology of inflammatory bowel diseases; a case report of a man with memory loss and odd behavior; and Perspective articles on reimagining how policymakers identify safety-net hospitals, on Medicaid and child health equity, on the FDA approval of remdesivir, and on whiteouts. Supplement to the New England Journal of Medicine, Vol. 383, No. 27.
December 30, 2020
NEJM This Week — December 24, 2020
Featuring articles on ultrasound subthalamotomy for Parkinson’s disease, antenatal dexamethasone for early preterm birth, oral azacitidine maintenance therapy for AML, paclitaxel-coated devices in peripheral artery disease, and seizure frequency during pregnancy; a review article on estrogen receptor–positive breast cancer; a case report of a man with headache and Covid-19; and Perspective articles on the gift; on new order, new hope; on resilience in the face of Covid-19; and on holding up. Supplement to the New England Journal of Medicine, Vol. 383, No. 26.
December 23, 2020
NEJM This Week — December 17, 2020
Featuring articles on SARS-CoV-2 transmission among Marine recruits, SARS-CoV-2 transmission on an aircraft carrier, an mRNA vaccine against Covid-19 in older adults, a phase 1 trial of an RNA-based Covid-19 vaccine, and the cardiomyocyte and the mighty mitochondrion; a review article on severe Covid-19; a case report of a boy with seizure and hypocalcemia; and Perspective articles on health coverage and care for transgender people, on rethinking sex designations on birth certificates, on being interviewed while Black, and on the caregiver. Supplement to the New England Journal of Medicine, Vol. 383, No. 25.
December 16, 2020
NEJM This Week — December 10, 2020
Featuring articles on lipid lowering through activation of lipoprotein lipase, on a SARS-CoV-2 recombinant nanoparticle vaccine, on tocilizumab in Covid-19, and on survival with olaparib in prostate cancer; a review article on spontaneous coronary-artery dissection; a case report of a man with cancer and acute hypoxemia; and Perspective articles on the discovery of hepatitis C, on how Medicare Part D has failed to deliver savings to older adults, on a pandemic within a pandemic, and on Telephone. Supplement to the New England Journal of Medicine, Vol. 383, No. 24.
December 9, 2020
NEJM This Week — December 3, 2020
Featuring articles on pembrolizumab in microsatellite-unstable colorectal cancer, the effect of finerenone on chronic kidney disease outcomes, person-to-person spread of Andes virus, malaria chemoprophylaxis in sub-saharan Africa, and epigenetic regulation in prostate cancer; a review article on cytokine storm; a Clinical Problem-Solving on looking for the outsider; and Perspective articles on solving population-wide obesity, on the bottom of the health care rationing iceberg, on understanding questions and answers about Covid-19 vaccination, and on why we need black physicians in academic medicine. Supplement to the New England Journal of Medicine, Vol. 383, No. 23.
December 2, 2020
NEJM This Week — November 26, 2020
We discuss the latest in medical research and ideas.
November 25, 2020
NEJM This Week — November 19, 2020
Featuring articles on golimumab and beta-cell function in type 1 diabetes, lorlatinib in ALK-positive lung cancer, hydroxychloroquine in patients with Covid-19, hydroxychloroquine with or without azithromycin in Covid-19, crafty killing of pathogenic microbes in the placenta, and physician–public defender collaboration; a review article on endometrial cancer; a case report of a woman with dark urine and weakness; and Perspective articles on the regulation of over-the-counter hearing aids, on transgender women on college athletic teams, and on unclaimed bodies in the anatomy lab. Supplement to the New England Journal of Medicine, Vol. 383, No. 21.
November 18, 2020
NEJM This Week — November 12, 2020
We discuss the latest in medical research and ideas.
November 11, 2020
NEJM This Week — November 5, 2020
We discuss the latest in medical research and ideas.
November 4, 2020
NEJM This Week — October 29, 2020
Featuring articles on osimertinib adjuvant therapy in EGFR-mutated non–small-cell lung cancer, a durable humoral response to SARS-CoV-2, low-dose edoxaban in atrial fibrillation, and exome sequencing for nonimmune hydrops fetalis; a review article on mild or moderate Covid-19; a case report of a man with chronic kidney disease; and Perspective articles on Operation Warp Speed’s strategy and approach, on evaluating and deploying Covid-19 vaccines, on pharmaceutical industry caution vs. federal acceleration of Covid-19 vaccine approval, and on the new stability. Supplement to the New England Journal of Medicine, Vol. 383, No. 18.
October 28, 2020
NEJM This Week — October 22, 2020
Featuring articles on dasatinib–blinatumomab in Ph-positive ALL, an anti–Siglec-8 antibody in gastritis and duodenitis, inhaled molgramostim therapy in autoimmune pulmonary alveolar proteinosis, treating Middle East Respiratory Syndrome, fibroblasts in rheumatoid arthritis, and how can we bridge the partisan divide and conquer Covid; a review article on sensory ganglionopathy; a case report of a man with abdominal pain, joint swelling, and skin lesions; and Perspective articles on whether the elections can end the health reform stalemate, on insurance coverage after job loss, on redoubling efforts to help Americans quit smoking, and on taking back our voices. Supplement to the New England Journal of Medicine, Vol. 383, No. 17.
October 21, 2020
NEJM This Week — October 15, 2020
Featuring articles on upadacitinib or abatacept in rheumatoid arthritis, a nimble GWAS on Covid-19, life expectancy after bariatric surgery, an mRNA–based Covid-19 vaccine in nonhuman primates, and selection against pathogenic mitochondrial DNA; a review article on autophagy in human diseases; a case report of a man with confusion, fatigue, and garbled speech; and Perspective articles on health policy in a Biden administration or after a Trump election victory, on Covid-19 and the mandate to redefine preventive care, and on when all you have is quality of life. Supplement to the New England Journal of Medicine, Vol. 383, No. 16.
October 14, 2020
NEJM This Week — October 8, 2020
Featuring articles on empagliflozin in heart failure, cardiovascular outcomes with ertugliflozin in diabetes, dapagliflozin in chronic kidney disease, single or dual antiplatelet treatment after TAVI, on dying in a leadership vacuum, Covid-19 and implications for the health care system, and mending mitochondrial mutation; a review article on secondary mitral regurgitation; a case report of a man with lymphoma and abdominal pain; and Perspective articles on the role of market forces in U.S. health care, on embracing antiracism in medicine, and on improving clinical trial enrollment. Supplement to the New England Journal of Medicine, Vol. 383, No. 15.
October 7, 2020
NEJM This Week — October 1, 2020
Featuring articles on early rhythm-control therapy for atrial fibrillation, evolocumab in heterozygous pediatric familial hypercholesterolemia, atezolizumab in non–small-cell lung cancer, HPV vaccination and the risk of cervical cancer, and physician work hours and the gender pay gap; a review article on myelodysplastic syndromes; a Clinical Problem-Solving describing parroting lymphoma; and Perspective articles on health in aging, on ensuring uptake of vaccines against SARS-CoV-2, on an innovative approach to reducing gun suicides, and on the ritual of the table. Supplement to the New England Journal of Medicine, Vol. 383, No. 14.
September 30, 2020
NEJM This Week — September 24, 2020
Featuring articles on a RAS oncogene inhibitor at last, avelumab maintenance therapy in bladder cancer, lower-dose zinc for childhood diarrhea, antisense oligonucleotides for hereditary angioedema, and sussing out the sestrins; a review article on congenital adrenal hyperplasia due to 21-hydroxylase deficiency; a case report of a man with sudden cardiac arrest; and Perspective articles on competing visions for the future of health policy, on assessing the safety of glucose-lowering drugs, on Ebola response priorities in the time of Covid-19, and on a farewell gift from a mother. Supplement to the New England Journal of Medicine, Vol. 383, No. 13.
September 23, 2020
NEJM This Week — September 17, 2020
Featuring articles on exome sequencing analysis in stillbirth, a two-year trial of belimumab in lupus nephritis, nocturnal oxygen in COPD, adjuvant targeted therapy in melanoma, and daratumumab in refractory lupus; a review article on immune tolerance; a case report of a man with fever and shortness of breath after liver transplantation; and Perspective articles on consent to trainee involvement in pediatric care, on examining examinations conducted under anesthesia, on June Medical Services v. Russo, and on sticks and stones. Supplement to the New England Journal of Medicine, Vol. 383, No. 12.
September 16, 2020
NEJM This Week — September 10, 2020
Featuring articles on strategies for tracheostomy decannulation, extending factor VIII activity in hemophilia A, eflornithine–sulindac in familial adenomatous polyposis, darolutamide in castration-resistant prostate cancer, the NIH RADx initiative, and on training innate immunity; a review article on pharmacologic treatment of ADHD; a case report of a man with intrusive thoughts and fear of poisoning; and Perspective articles on health equity, on the cancer risk associated with lorcaserin, on whether Covid can catalyze an educational transformation, and on the ideal intern. Supplement to the New England Journal of Medicine, Vol. 383, No. 11.
September 9, 2020
NEJM This Week — September 3, 2020
Featuring articles on weight loss in underserved patients, the effect of phenylbutyrate–taurursodiol on ALS progression, tepotinib in lung cancer, capmatinib in MET-altered lung cancer, and reopening primary schools during the pandemic; a review article on pulmonary fibrotic diseases; a Clinical Problem-Solving describing a curve ball; and Perspective articles on progress in cancer research, prevention, and care; on public health decision making during Covid-19; on long-term care policy after Covid-19; and on the tragedy of measles. Supplement to the New England Journal of Medicine, Vol. 383, No. 10.
September 2, 2020
NEJM This Week — August 27, 2020
Featuring articles on selpercatinib in RET fusion–positive lung cancer, selpercatinib for medullary thyroid cancer, a closed-loop system in children with type 1 diabetes, sticky findings in breast cancer, and reconsidering the use of race correction in clinical algorithms; a review article on atherosclerotic plaque healing; a case report of a woman with headache and gait imbalance; and Perspective articles on improving the quality of U.S. health care, on Covid-19 and immunity in aging populations, and on U.S. efforts to curb antibiotic resistance. Supplement to the New England Journal of Medicine, Vol. 383, No. 9.
August 26, 2020
NEJM This Week — August 20, 2020
Featuring articles on evinacumab for familial hypercholesterolemia, the effects of diet vs. gastric bypass in diabetes, drug-coated balloons for dysfunctional dialysis arteriovenous fistulas, fracture risk vs. fracture prevention with bisphosphonates, and the challenges of “return to work” in an ongoing pandemic; a review article on trigeminal neuralgia; a case report of a woman with altered mental status and weakness on the left side; and Perspective articles on low-threshold buprenorphine initiation, on when prescribing isn’t enough, on the death throes of Mercy, and on when the EMR stole a doctor’s pen. Supplement to the New England Journal of Medicine, Vol. 383, No. 8.
August 19, 2020
NEJM This Week — August 13, 2020
Featuring articles on azacitidine plus venetoclax in AML, compression for recurrent cellulitis of the leg, decreased population-based mortality from lung cancer, the United States and the WHO, the need for a tighter particulate-matter air-quality standard, and bilirubin in IBD and pancreatitis; a review article on epigenetic therapies for cancer; a case report of a woman with a lung mass; and Perspective articles on whether we spend too much on health care, on people with hepatitis C who inject drugs, on hepatitis C treatment in correctional facilities, and on a national medical response to crisis. Supplement to the New England Journal of Medicine, Vol. 383, No. 7.
August 12, 2020
NEJM This Week — August 6, 2020
Featuring articles on hydroxychloroquine for Covid-19 prophylaxis, subcutaneous or transvenous ICD therapy, Zika virus disease in Colombia, ofatumumab vs. teriflunomide in multiple sclerosis, and spending after state specialty-drug out-of-pocket caps; a review article on native-valve infective endocarditis; a Clinical Problem-Solving on being led astray; and Perspective articles on the National Academy of Medicine and the quality of health care, on care churn, on mental health and the Covid-19 pandemic, and on preventing a parallel pandemic. Supplement to the New England Journal of Medicine, Vol. 383, No. 6.
August 5, 2020
NEJM This Week — July 30, 2020
Featuring articles on nirsevimab for the prevention of RSV disease, RSV vaccination during pregnancy to protect infants, uterine-artery embolization or myomectomy for uterine fibroids, a trial of a therapeutic anti–yellow fever virus antibody, and a bad acid trip for sarcomas; a review article on chronic lymphocytic leukemia; a case report of a woman with chest pain, dyspnea, and shock; and Perspective articles on health care as an ongoing policy project, on Covid’s color line, and on the illusion of inclusion. Supplement to the New England Journal of Medicine, Vol. 383, No. 5.
July 29, 2020
About NEJM This Week – Audio Summaries
The New England Journal of Medicine (NEJM) Weekly Audio Summary RSS Feed. NEJM is a weekly general medicinal journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.
Never miss NEJM This Week – Audio Summaries
Join Our NewsletterWe gratefully acknowledge the many organizations that have generously supported our podcasts and platform.
Network Sponsors and Advertisers
Event and Media Partners
